Pinstripes (PNST) 10-Q 26 Nov 24 2025 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Oct. 13, 2024	Nov. 22, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 13, 2024
Document Transition Report	false
Entity File Number	001-41236
Entity Registrant Name	Pinstripes Holdings, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-2556699
Entity Address, Address Line One	1150 Willow Road
Entity Address, City or Town	Northbrook
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60062
City Area Code	847
Local Phone Number	480-2323
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001852633
Current Fiscal Year End Date	--04-27
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Class A Common Stock
Document Information [Line Items]
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	PNST
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		40,087,785
Redeemable Warrants
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, exercisable for one share of Class A Common Stock, exercise price of $11.50 per share
Trading Symbol	PNST WS
Security Exchange Name	NYSE
Class B-1 Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		0
Class B-3 Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		0
Class B-2 Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		0

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 13, 2024	Apr. 28, 2024
Current Assets
Cash and cash equivalents	$ 3,244	$ 13,171
Accounts receivable	1,339	1,137
Inventories	860	949
Prepaid expenses and other current assets	1,396	2,101
Total current assets	6,839	17,358
Property and equipment, net	77,265	80,015
Operating lease right-of-use assets	74,672	66,362
Other long-term assets	2,659	3,586
Total assets	161,435	167,321
Current Liabilities
Current portion of long-term notes payable	6,659	4,818
Accrued occupancy costs	8,365	6,508
Other accrued liabilities	9,015	6,546
Current portion of operating lease liabilities	15,243	15,259
Warrant liabilities	766	5,411
Total current liabilities	72,544	69,881
Long-term notes payable	77,447	70,677
Long-term accrued occupancy costs	158	277
Operating lease liabilities	96,972	94,256
Other long-term liabilities	3,168	1,386
Total liabilities	250,289	236,477
Commitments and contingencies (Note 12)
Stockholders’ deficit
Common stock (par value: $0.0001; authorized: 430,000,000 shares; issued and outstanding: 40,087,785 shares at October 13, 2024 and 40,087,785 shares at April 28, 2024)	4	4
Additional paid-in capital	56,244	56,623
Accumulated deficit	(145,102)	(125,783)
Total stockholders’ deficit	(88,854)	(69,156)
Total liabilities, redeemable convertible preferred stock, and stockholders’ deficit	161,435	167,321
Nonrelated Party
Current Liabilities
Accounts payable	23,014	22,706
Related Party
Current Liabilities
Accounts payable	$ 9,482	$ 8,633

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 13, 2024	Apr. 28, 2024	Dec. 29, 2023	Dec. 28, 2023	Apr. 30, 2023
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001			$ 0.0001
Common stock, shares authorized (in shares)	430,000,000	430,000,000
Common stock, shares issued (in shares)	40,087,785	40,087,785		17,422,009
Common stock, shares outstanding (in shares)	40,087,785	40,087,785	39,918,036	17,422,009

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended
	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024
Total revenue	$ 26,482	$ 24,623	$ 50,364	$ 57,077
Store labor and benefits	10,308	9,337	18,634	21,966
Store occupancy costs, excluding depreciation	4,932	4,583	5,590	11,487
Other store operating expenses, excluding depreciation	5,283	5,134	9,556	10,714
General and administrative expenses	5,080	3,774	7,302	10,584
Depreciation expense	2,547	1,697	3,341	5,065
Pre-opening expenses	1,568	3,026	5,304	2,574
Operating loss	(7,874)	(7,206)	(8,078)	(15,486)
Interest expense, net	(4,898)	(1,908)	(3,601)	(9,892)
Gain on change in fair value of warrant liabilities and other	3,573	1,759	1,350	6,248
Other expense	(48)	0	0	(48)
Loss before income taxes	(9,247)	(7,355)	(10,329)	(19,178)
Income tax expense (benefit)	63	(72)	0	138
Net loss	(9,310)	(7,283)	(10,329)	(19,316)
Less: Cumulative unpaid dividends and change in redemption amount of redeemable convertible preferred stock	0	(394)	(1,951)	0
Net loss attributable to common stockholders	(9,310)	(7,677)	(12,280)	(19,316)
Net loss attributable to common stockholders	$ (9,310)	$ (7,677)	$ (12,280)	$ (19,316)
Basic loss per share (in dollars per share)	$ (0.22)	$ (0.64)	$ (1.02)	$ (0.45)
Diluted loss per share (in dollars per share)	$ (0.22)	$ (0.64)	$ (1.02)	$ (0.45)
Weighted average common shares outstanding, basic (in shares)	43,099,877	12,066,454	12,094,424	42,905,215
Weighted average common shares outstanding, diluted (in shares)	43,099,877	12,066,454	12,094,424	42,905,215
Food and beverage revenues
Total revenue	$ 21,108	$ 19,435	$ 39,952	$ 44,927
Cost of food and beverage	4,638	4,278	8,715	10,173
Recreation revenues
Total revenue	$ 5,374	$ 5,188	$ 10,412	$ 12,150

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($) $ in Thousands		Total	Previously Reported	Revision of Prior Period, Adjustment	Series I Preferred Stock	Common Stock	Common Stock Previously Reported	Common Stock Revision of Prior Period, Adjustment	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Additional Paid-In Capital Revision of Prior Period, Adjustment	Accumulated Deficit	Accumulated Deficit Previously Reported
Beginning balance (in shares) at Apr. 30, 2023	[1]	18,863,090	10,203,945	8,659,145
Beginning balance at Apr. 30, 2023		$ 53,468	$ 53,468		$ 0
Increase (Decrease) in Temporary Equity
Issuance of Series I Redeemable Convertible Preferred Stock (in shares)	[1]				1,988,620
Issuance of Series I Redeemable Convertible Preferred Stock					$ 18,463
Accretion of cumulative dividends on Series I Redeemable Convertible Preferred Stock		134
Change in the redemption value of the Redeemable Convertible Preferred Stock		$ 1,423
Ending balance (in shares) at Jul. 23, 2023	[1]	20,851,710
Ending balance at Jul. 23, 2023		$ 73,488
Beginning balance (in shares) at Apr. 30, 2023	[1]					11,422,476	6,178,962	5,243,514
Beginning balance at Apr. 30, 2023		(114,998)	$ (114,998)	$ 0		$ 1	$ 62	$ (61)	$ 3,794	$ 3,733	$ 61	$ (118,793)	$ (118,793)
Increase (Decrease) in Stockholders' Equity
Net loss		(3,046)										(3,046)
Accretion of cumulative dividends on Series I Redeemable Convertible Preferred Stock		(134)							(134)
Change in the redemption value of the Redeemable Convertible Preferred Stock		(1,423)							(1,423)
Stock-based compensation		141							141
Ending balance (in shares) at Jul. 23, 2023	[1]					11,422,476
Ending balance at Jul. 23, 2023		$ (119,460)				$ 1			2,378			(121,839)
Beginning balance (in shares) at Apr. 30, 2023	[1]	18,863,090	10,203,945	8,659,145
Beginning balance at Apr. 30, 2023		$ 53,468	$ 53,468		0
Ending balance (in shares) at Oct. 15, 2023	[1]	20,989,710
Ending balance at Oct. 15, 2023		$ 75,262
Beginning balance (in shares) at Apr. 30, 2023	[1]					11,422,476	6,178,962	5,243,514
Beginning balance at Apr. 30, 2023		(114,998)	$ (114,998)	$ 0		$ 1	$ 62	$ (61)	3,794	3,733	61	(118,793)	(118,793)
Increase (Decrease) in Stockholders' Equity
Net loss		(10,329)
Reclassification of liability-classified warrants		0
Issuance of contingently issuable warrants		0
Change in the redemption value of the Redeemable Convertible Preferred Stock		(1,423)
Ending balance (in shares) at Oct. 15, 2023	[1]					11,422,476
Ending balance at Oct. 15, 2023		$ (128,578)				$ 1			543			(129,122)
Beginning balance (in shares) at Apr. 30, 2023	[1]	18,863,090	10,203,945	8,659,145
Beginning balance at Apr. 30, 2023		$ 53,468	$ 53,468		0
Increase (Decrease) in Temporary Equity
Issuance of Series I Redeemable Convertible Preferred Stock		19,843			19,843
Accretion of cumulative dividends on Series I Redeemable Convertible Preferred Stock		878			878
Change in the redemption value of the Redeemable Convertible Preferred Stock		$ 1,423			1,423
Ending balance (in shares) at Apr. 28, 2024		0
Ending balance at Apr. 28, 2024		$ 0			$ 0
Beginning balance (in shares) at Apr. 30, 2023	[1]					11,422,476	6,178,962	5,243,514
Beginning balance at Apr. 30, 2023		$ (114,998)	$ (114,998)	$ 0		$ 1	$ 62	$ (61)	3,794	$ 3,733	$ 61	(118,793)	$ (118,793)
Ending balance (in shares) at Apr. 28, 2024		40,087,785				40,087,785,000
Ending balance at Apr. 28, 2024		$ (69,156)				$ 4			56,623			(125,783)
Beginning balance (in shares) at Jul. 23, 2023	[1]	20,851,710
Beginning balance at Jul. 23, 2023		$ 73,488
Increase (Decrease) in Temporary Equity
Issuance of Series I Redeemable Convertible Preferred Stock (in shares)	[1]				138,000
Issuance of Series I Redeemable Convertible Preferred Stock					$ 1,380
Accretion of cumulative dividends on Series I Redeemable Convertible Preferred Stock		$ 394
Ending balance (in shares) at Oct. 15, 2023	[1]	20,989,710
Ending balance at Oct. 15, 2023		$ 75,262
Beginning balance (in shares) at Jul. 23, 2023	[1]					11,422,476
Beginning balance at Jul. 23, 2023		(119,460)				$ 1			2,378			(121,839)
Increase (Decrease) in Stockholders' Equity
Net loss		(7,283)										(7,283)
Reclassification of liability-classified warrants		(1,834)							(1,834)
Accretion of cumulative dividends on Series I Redeemable Convertible Preferred Stock		(394)							(394)
Issuance of warrants		173							173
Stock-based compensation		220							220
Ending balance (in shares) at Oct. 15, 2023	[1]					11,422,476
Ending balance at Oct. 15, 2023		$ (128,578)				$ 1			543			(129,122)
Beginning balance (in shares) at Dec. 28, 2023		17,422,009
Ending balance (in shares) at Dec. 29, 2023		39,918,036
Beginning balance (in shares) at Apr. 28, 2024		0
Beginning balance at Apr. 28, 2024		$ 0			0
Ending balance (in shares) at Jul. 21, 2024		0
Ending balance at Jul. 21, 2024		$ 0
Beginning balance (in shares) at Apr. 28, 2024		40,087,785				40,087,785,000
Beginning balance at Apr. 28, 2024		$ (69,156)				$ 4			56,623			(125,783)
Increase (Decrease) in Stockholders' Equity
Net loss		(10,006)										(10,006)
Transaction costs incurred in connection with the registration statements		(101)							(101)
Prior period adjustment		25							28			(3)
Stock-based compensation		546							546
Ending balance (in shares) at Jul. 21, 2024						40,087,785,000
Ending balance at Jul. 21, 2024		$ (78,692)				$ 4			57,096			(135,792)
Beginning balance (in shares) at Apr. 28, 2024		0
Beginning balance at Apr. 28, 2024		$ 0			$ 0
Ending balance (in shares) at Oct. 13, 2024		0
Ending balance at Oct. 13, 2024		$ 0
Beginning balance (in shares) at Apr. 28, 2024		40,087,785				40,087,785,000
Beginning balance at Apr. 28, 2024		$ (69,156)				$ 4			56,623			(125,783)
Increase (Decrease) in Stockholders' Equity
Net loss		(19,316)
Reclassification of liability-classified warrants		1,864
Issuance of contingently issuable warrants		401
Change in the redemption value of the Redeemable Convertible Preferred Stock		$ 0
Ending balance (in shares) at Oct. 13, 2024		40,087,785				40,087,785,000
Ending balance at Oct. 13, 2024		$ (88,854)				$ 4			56,244			(145,102)
Beginning balance (in shares) at Jul. 21, 2024		0
Beginning balance at Jul. 21, 2024		$ 0
Ending balance (in shares) at Oct. 13, 2024		0
Ending balance at Oct. 13, 2024		$ 0
Beginning balance (in shares) at Jul. 21, 2024						40,087,785,000
Beginning balance at Jul. 21, 2024		(78,692)				$ 4			57,096			(135,792)
Increase (Decrease) in Stockholders' Equity
Net loss		(9,310)										(9,310)
Transaction costs incurred in connection with the registration statements		25							25
Reclassification of liability-classified warrants		(1,864)							(1,864)
Issuance of contingently issuable warrants		401							401
Issuance of warrants		67							67
Stock-based compensation		$ 519							519
Ending balance (in shares) at Oct. 13, 2024		40,087,785				40,087,785,000
Ending balance at Oct. 13, 2024		$ (88,854)				$ 4			$ 56,244			$ (145,102)
[1]The number of shares of Redeemable Convertible Preferred Stock and Common Stock issued and outstanding prior to the Reverse Recapitalization have been retroactively adjusted by the Exchange Ratios to give effect to the Reverse Recapitalization. See Note 2.

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	5 Months Ended	6 Months Ended
	Oct. 15, 2023	Oct. 13, 2024
Cash flows from operating activities
Net loss	$ (10,329)	$ (19,316)
Adjustments to reconcile net loss to net cash used in operating activities
Gain on modification of operating leases	(3,281)	0
Depreciation expense	3,341	5,065
Non-cash operating lease expense	2,646	3,136
Paid-in-kind interest	0	4,942
Operating lease tenant allowances	1,272	(863)
Stock-based compensation	361	1,065
Gain on change in fair value of warrant liabilities and other	(1,350)	(6,248)
Warrant expense	0	28
Interest on finance lease obligation	0	24
Amortization of debt issuance costs	897	1,199
Accounts receivable	188	(202)
Inventories	(28)	89
Prepaid expenses and other current assets	(85)	705
Operating right-of-use asset	0	(3,602)
Other long-term assets	(5,005)	927
Accrued occupancy costs	(4,210)	1,738
Other accrued liabilities	289	3,416
Operating lease liabilities	(4,697)	(5,144)
Net cash (used in) operating activities	(15,924)	(10,140)
Cash flows from investing activities
Purchase of property and equipment	(9,793)	(2,810)
Net cash (used in) investing activities	(9,793)	(2,810)
Cash flows from financing activities
Proceeds from issuance of redeemable convertible preferred stock, net	19,843	0
Payment of transaction costs incurred in connection with the registration statements	(1,540)	(10)
Principal payments on finance lease obligation	0	(73)
Principal payments on long-term notes payable	(283)	(1,858)
Proceeds from warrant issuances	0	67
Debt issuance costs	(247)	76
Proceeds from long-term notes payable, net	7,499	4,821
Net cash provided by financing activities	25,272	3,023
Net change in cash and cash equivalents	(445)	(9,927)
Cash and cash equivalents, beginning of period	8,436	13,171
Cash and cash equivalents, end of period	7,991	3,244
Supplemental disclosures of cash flow information
Cash paid for interest	2,287	3,197
Cash paid for income taxes	0	61
Supplemental disclosures of non-cash operating, investing and financing activities
Transaction costs incurred in connection with the registration statements but not yet paid	0	66
Operating lease rent abatement	3,214	0
Right-of-use assets obtained in exchange for lease liabilities	(560)	7,844
Non-cash finance obligation	665	360
Issuance of contingently issuable warrants	0	401
Reclassification of liability-classified warrants	0	1,864
Reclassification of Oaktree Tranche 2 Written Option from short-term to long-term	0	1,012
Non-cash capital expenditures included in accounts payable	2,798	1,719
Change in the redemption amount of the redeemable convertible preferred stock	1,423	0
Accretion of cumulative dividends on Series I redeemable convertible preferred stock	528	0
Nonrelated Party
Adjustments to reconcile net loss to net cash used in operating activities
Accounts payable	3,258	2,052
Related Party
Adjustments to reconcile net loss to net cash used in operating activities
Accounts payable	$ 809	$ 849

Nature of Business and Basis of

Nature of Business and Basis of Presentation	6 Months Ended
	Oct. 13, 2024
Accounting Policies [Abstract]
Nature of Business and Basis of Presentation	Nature of Business and Basis of Presentation Pinstripes Holdings, Inc. (“Pinstripes”, “New Pinstripes”, the “Company”, “we”, “us”, or “our”) was formed for the purpose of operating and expanding a unique entertainment and dining concept. As of October 13, 2024, the Company has 17 locations in ten states and Washington D.C. and generates revenue primarily from the sale of food, beverages, bowling, bocce and hosting private events. The Company operates its business as one operating and one reportable segment. On December 29, 2023, Pinstripes, Inc. (the “Predecessor” or “Legacy Pinstripes”) consummated the previously announced business combination pursuant to the Business Combination Agreement, dated as of June 22, 2023 (as amended and restated as of September 26, 2023 and November 22, 2023, the “BCA” or “Business Combination”), by and among Legacy Pinstripes, Banyan Acquisition Corporation, a Delaware corporation (“Banyan”), and Panther Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Banyan. The financial statements included in this report reflect (i) the historical operating results of Legacy Pinstripes prior to the Business Combination and (ii) the combined results of Legacy Pinstripes and New Pinstripes following the closing of the Business Combination (collectively, Legacy Pinstripes and New Pinstripes are referred to as the “Company”). In connection with the closing of the Business Combination, Banyan changed its name to Pinstripes Holdings, Inc. (see Note 2). The closing of the Business Combination is accounted for as a reverse recapitalization. The prior period share and per share amounts presented in the unaudited condensed consolidated financial statements and related notes have been retroactively adjusted to give effect to the reverse recapitalization treatment of the transactions completed by the Business Combination. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its directly and indirectly wholly owned subsidiaries: Pinstripes, Inc., Pinstripes at Prairiefire, Inc., Pinstripes Illinois, LLC, and Pinstripes, Hillsdale, LLC. All intercompany accounts and transactions have been eliminated in consolidation. Fiscal Years The Company’s fiscal year consists of 52/53-weeks ending on the last Sunday in April. The fiscal year ended April 28, 2024 contained 52 weeks. In a 52-week fiscal year, the first, second and third fiscal quarters each contain twelve weeks and the fourth fiscal quarter contains sixteen weeks. In a 53-week fiscal year, the first, second and third fiscal quarters each contain twelve weeks and the fourth fiscal quarter contains seventeen weeks. Interim Financial Statements The Company’s financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) in the United States for interim financial information as prescribed by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all the information and notes required by GAAP for complete financial statements. In the opinion of management, these financial statements contain all adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position, results of operations and cash flows for the periods indicated. Certain information and footnote disclosures normally included in annual financial statements presented in accordance with GAAP have been omitted pursuant to rules and regulations of the SEC. Due to the seasonality of the Company’s business, results for any interim financial period are not necessarily indicative of the results that may be achieved for a full fiscal year. In addition, quarterly results of operations may be impacted by the timing and amount of sales and costs associated with opening new locations. These interim unaudited condensed consolidated financial statements do not represent complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended April 28, 2024, included in the 2024 Annual Report, which was filed with the SEC on June 28, 2024. Use of Estimates The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Cash and cash equivalents Management considers transaction settlements in process from credit card companies and all highly-liquid investments with original maturities of three months or less to be cash equivalents. Amounts due from credit card transactions with settlement terms of less than five days are included in cash and cash equivalents. Credit and debit card receivables included within cash were $1,294 and $1,624 as of October 13, 2024 and April 28, 2024, respectively. Revenue Food and beverage revenues and recreation revenues are recognized when payment is tendered at the point of sale as the performance obligation has been satisfied. Food and beverage revenues include the sale of food and beverage products. Recreation revenues include bowling and bocce sales. Revenues are recognized net of discounts and taxes. Event deposits received from guests are deferred and recognized as revenue when the event is held. Event deposits received from customers in advance are included in amounts due to customers in the condensed consolidated balance sheets in the amounts of $7,739 as of October 13, 2024 and $6,640 as of April 28, 2024. The Company sells gift cards, which do not have expiration dates, and does not deduct non-usage fees from outstanding gift card balances. Gift card sales are initially recorded by the Company as a liability and subsequently recognized as revenue upon redemption by the customer. For unredeemed gift cards that the Company expects to be entitled to breakage and for which there is no legal obligation to remit the unredeemed gift card balances to the relevant jurisdictions, the Company recognizes expected breakage as revenue in proportion to the pattern of redemption by the customers. The determination of the gift card breakage is based on the Company’s specific historical redemption patterns. The contract liability related to our gift cards is included in amounts due to customers in the condensed consolidated balance sheets in the amounts of $1,743 as of October 13, 2024 and $1,993 as of April 28, 2024. The components of gift card revenue were as follows: Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Redemptions, net of discounts $ 422 $ 369 $ 1,036 $ 883 Breakage $ 103 $ 103 $ 240 $ 245 Gift card revenue, net $ 525 $ 472 $ 1,276 $ 1,128 Revenues are reported net of sales tax collected from customers. Sales tax collected is included in other accrued liabilities on the condensed consolidated balance sheets until the taxes are remitted to the appropriate taxing authorities. Pre-opening costs Pre-opening costs, which are expensed as incurred, consist of expenses prior to opening a new store location and are made up primarily of manager salaries, relocation costs, recruiting expenses, payroll and training costs, marketing and travel costs. These costs also include occupancy costs recorded during the period between the date of possession and the date we begin operations at a location. Pre-opening costs were $1,568 and $2,574 for the twelve and twenty-four weeks ended October 13, 2024, respectively, compared to $3,026 and $5,304 for the twelve and twenty-four weeks ended October 15, 2023, respectively. The decrease was due to fewer locations under construction during the period. Common and preferred stock In connection with the Reverse Recapitalization (see Note 2), the following classes of common (collectively, the Class A Common Stock, Series B-1 Common Stock, Series B-2 Common Stock and Series B-3 Common Stock, are referred to as “Common Stock”) and preferred stock were authorized: • 400,000,000 shares of Class A Common Stock at a par value of $0.0001 per share, of which 40,087,785 shares were issued and outstanding as of October 13, 2024 • 10,000,000 shares of Series B-1 Common Stock at a par value of $0.0001 per share, of which no shares were issued and outstanding as of October 13, 2024 • 10,000,000 shares of Series B-2 Common Stock at a par value of $0.0001 per share, of which no shares were issued and outstanding as of October 13, 2024 • 10,000,000 shares of Series B-3 Common Stock at a par value of $0.0001 per share, of which no shares were issued and outstanding as of October 13, 2024 • 10,000,000 shares of preferred stock at a par value of $0.0001 per share, of which no shares were issued and outstanding as of October 13, 2024 Recently adopted and issued accounting standards In November 2023, the FASB issued Update 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures". This Update applies to all public entities that are required to report segment information in accordance with Topic 280. The amendments in this Update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this Update do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The new standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The standard should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adopting this new standard. In December 2023, the FASB issued Update 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures". This Update applies to all entities that are subject to Topic 740. The amendments in this Update improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information as well as the effectiveness of certain other income tax disclosures. The new standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The standard should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the impact of adopting this new standard. Management reviewed the accounting pronouncements that became effective for the second quarter of fiscal year 2024 and determined that either they were not applicable, or they did not have a material impact on the condensed consolidated financial statements. Management also reviewed the recently issued accounting pronouncements to be adopted in future periods and determined that they are not expected to have a material impact on the condensed consolidated financial statements.

Reverse Recapitalization

Reverse Recapitalization	6 Months Ended
	Oct. 13, 2024
Reverse Recapitalization [Abstract]
Reverse Recapitalization	Reverse Recapitalization The consummation of the Business Combination was accounted for as a reverse recapitalization in accordance with GAAP (“Reverse Recapitalization”). Under this method of accounting, Banyan is treated as the “acquired” company. Accordingly, for accounting and financial reporting purposes, the financial statements of the combined entity, New Pinstripes, represent a continuation of the condensed consolidated financial statements of Legacy Pinstripes, with the transaction treated as the equivalent of Legacy Pinstripes issuing stock for the net assets of Banyan, accompanied by a recapitalization. The net assets of Banyan are stated at historical cost, which approximates fair value, with no goodwill or other intangible assets recorded. Legacy Pinstripes was determined to be the accounting acquirer due to (i) Legacy Pinstripes’ stockholders comprising the relative majority of the voting power of the combined entity and having the ability to nominate the substantial majority of the board of directors of New Pinstripes, (ii) Legacy Pinstripes’ operations prior to the Reverse Recapitalization comprising the only ongoing operations of the combined entity, and (iii) Legacy Pinstripes’ senior management comprising the senior management of the combined company. In connection with the closing of the Business Combination: • Immediately prior to the consummation of the Reverse Recapitalization (i) each of the issued and outstanding 11,089,695 shares of Legacy Pinstripes Redeemable Convertible Preferred Stock (including the 850,648 shares of Legacy Pinstripes Series I Redeemable Convertible Preferred Stock and the 35,102 shares payable for the settlement of the cumulative unpaid dividends thereon) were converted into 11,089,695 shares of Legacy Pinstripes Common Stock; (ii) each of the issued and outstanding 354,436 Legacy Pinstripes warrants were converted into 354,436 shares of Legacy Pinstripes Common Stock; and (iii) each of Legacy Pinstripes outstanding principal convertible note obligations were converted into 500,000 shares of Legacy Pinstripes Common Stock (collectively, the “Conversion Shares”); • Each of the issued and outstanding 17,422,009 shares of Legacy Pinstripes Common Stock held by the Legacy Pinstripes stockholders, including the Conversion Shares, with the exception of the 885,750 shares of Legacy Pinstripes Common Stock issued upon conversion of Legacy Pinstripes Series I Redeemable Convertible Preferred Stock (the “Series I Investors”), were cancelled and converted into 32,206,458 shares of New Pinstripes Class A Common Stock, after giving effect to an exchange ratio of approximately 1.8486 shares of New Pinstripes Class A Common Stock for each share of Legacy Pinstripes as set forth in the BCA (the “Exchange Ratio”); • Each of the issued and outstanding 885,750 shares of Legacy Pinstripes Common Stock held by the Series I Investors were cancelled and converted into 2,214,375 shares of New Pinstripes Class A Common Stock after giving effect to an exchange ratio of approximately 2.5 shares of New Pinstripes Class A Common Stock for each share of Legacy Pinstripes as set forth in the BCA (the “Series I Exchange Ratio”) (collectively, the Exchange Ratio and the Series I Exchange Ratios are referred to as the “Exchange Ratios”); • All 32,203 of the issued and outstanding shares of Banyan Redeemable Class A Common Stock held by Banyan stockholders were re-issued as 32,203 shares of New Pinstripes Class A Common Stock; • Banyan stockholders forfeited an aggregate of 2,768,750 shares of the issued and outstanding Banyan Class A Common Stock which were re-issued as (i) 1,242,975 shares of New Pinstripes Class A Common Stock to the Legacy Pinstripes stockholders (other than the Series I Investors), (ii) 507,025 shares of New Pinstripes Class A Common Stock to the Series I Investors and (iii) 1,018,750 shares of Class A Common Stock to the certain investors in Banyan who agreed not to redeem their respective shares of Banyan Class A Common Stock in connection with Banyan’s extension meeting held on April 21, 2023; • Each of the remaining issued and outstanding 3,665,000 shares of Banyan Class A Common Stock held by the Banyan stockholders were re-issued as 3,665,000 shares of New Pinstripes Common Stock; • All of the 2,722,593 issued and outstanding vested and unvested Legacy Pinstripes options held by the Legacy Pinstripes stockholders were converted into New Pinstripes options exercisable for 5,032,434 shares of New Pinstripes Common Stock, after giving effect to the Exchange Ratio, at an exercise price per share equal to the Legacy Pinstripes option exercise price divided by the Exchange Ratio; and • 50,000 shares of New Pinstripes Class A Common Stock were issued to a third party as payment for $500 of transaction costs incurred by Legacy Pinstripes in connection with the closing of the business combination. Pursuant to the BCA, an aggregate of (i) 1,485,000 of the issued and outstanding shares of Banyan Class A Common Stock and 345,000 of the issued and outstanding shares of Banyan Class B Common Stock held by the Banyan stockholders were re-issued as 1,830,000 shares of New Pinstripes Class B Common Stock, subject to vesting based upon satisfaction of stock trading price conditions (“Sponsor Earnout Shares”), (ii) 5,000,000 shares of New Pinstripes Class B Common Stock were issued to Legacy Pinstripes stockholders, subject to vesting based upon satisfaction of stock trading price conditions (“Target Earnout Shares”), and (iii) 4,000,000 shares of New Pinstripes Class B Common Stock were issued to Legacy Pinstripes stockholders, subject to vesting based upon financial performance in calendar 2024 (“EBITDA Earnout Shares” and together with the Sponsor Earnout Shares and the Target Earnout Shares, the “Earnout Shares”). The Earnout Shares, which will convert into New Pinstripes Class A Common Stock if the conditions described herein are met, are subject to forfeiture if the respective achievement of the specified targets are not met, are classified in stockholders’ equity as the Earnout Shares were determined to be indexed to New Pinstripes Class A Common Stock and meet the requirements for equity classification. In connection with the Reverse Recapitalization, Pinstripes entered into a loan agreement with Oaktree Fund Administration, LLC (“Oaktree”) under which Pinstripes obtained a senior secured term loan in the principal amount of $50,000 (see Note 5) and issued warrants to purchase 2,500,000 shares of New Pinstripes Class A Common Stock at an exercise price of $0.01 per share (“ Oaktree Tranche 1 Warrants”). Management evaluated the warrants and concluded the meet the criteria for equity classification (see Note 10). The number of shares of New Pinstripes Class A Common Stock issued immediately following the consummation of the Reverse Capitalization was as follows: Shares Legacy Pinstripes stockholders (1) 33,449,433 Banyan stockholders (2) 3,697,203 Series I Investors 2,721,400 Other 50,000 Total shares of New Pinstripes Class A Common Stock outstanding immediately following the Reverse Recapitalization 39,918,036 (1) Excludes the 5,000,000 Target Earnout Shares and the 4,000,000 EBITDA Earnout shares subject to forfeiture if the achievement of certain targets is not met. (2) Includes the 1,018,750 shares of New Pinstripes Class A Common Stock to certain investors in Banyan who agreed not to redeem their respective shares of Banyan Class A Common Stock in connection with Banyan’s extension meeting held on April 21, 2023 and excludes the 1,830,000 Sponsor Earnout Shares subject to forfeiture if the achievement of certain targets is not met. Transaction Costs During the twelve and twenty-four weeks ended October 13, 2024, the Company incurred $(25) and $76, respectively, for transaction costs incurred in connection with the S-1 registration statement. For the twelve weeks ended October 13, 2024, the Company incurred $25 for transaction costs offset by a $(50) adjustment to transaction costs. During the twelve and twenty-four weeks ended October 15, 2023, the Company incurred $1,367 and $4,126, respectively, for transaction costs incurred in connection with the Reverse Recapitalization. The transaction costs primarily represent fees incurred for financial advisory, legal and other professional services. Of the total transaction costs incurred during the twelve and twenty-four weeks ended October 13, 2024, $10 have been paid. During the fiscal year ended April 28, 2024, the Company incurred $24,317 for transaction costs incurred in connection with the Reverse Recapitalization, inclusive of Banyan incurred transaction costs, and $635 for transaction costs incurred with the S-1 and S-8 registration statements. Transaction costs are reported as a reduction of additional paid-in capital on the condensed consolidated balance sheets as of October 13, 2024 and April 28, 2024, excluding $940 reported as prepaid and other current assets related to director and officer insurance for the Company and Banyan as well as $53 of taxes payable related to the consummation of the Business Combination. Retroactive Application of Reverse Recapitalizatio n The Business Combination is accounted for as a reverse recapitalization of equity. Accordingly, the prior period share and per share amounts presented in the condensed consolidated financial statements and related notes have been retroactively adjusted to give effect to the Reverse Recapitalization. Retroactive Application of Reverse Recapitalization to the Unaudited Condensed Consolidated Statements of Operations The weighted average shares during the twelve and twenty-four weeks ended October 15, 2023 have been recalculated to give effect to the retroactive application of the Reverse Recapitalization on the outstanding shares. Accordingly, the basic and diluted weighted-average Legacy Pinstripes Common Stock were retroactively converted to New Pinstripes Common Stock. Retroactive Application of Reverse Recapitalization to the Unaudited Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Deficit The unaudited condensed consolidated statements of redeemable convertible preferred stock and stockholders’ deficit for the twelve and twenty-four weeks ended October 15, 2023 have been recast to reflect the number of New Pinstripes Common Stock issued to Legacy Pinstripes stockholders in connection with the Reverse Recapitalization at the New Pinstripes Common Stock par value of $0.0001. The number of Legacy Pinstripes’ Redeemable Convertible Preferred Stock and Legacy Pinstripes’ Common Stock have been recast after giving effect to the Exchange Ratio in connection with the Reverse Recapitalization, and the related impacts to common stock and additional paid-in-capital for the change in par value.

Inventory

Inventory	6 Months Ended
	Oct. 13, 2024
Inventory Disclosure [Abstract]
Inventory	Inventory Inventories consist of the following: October 13, 2024 April 28, 2024 Beverage $ 606 $ 672 Food 254 277 Total $ 860 $ 949

Property and Equipment

Property and Equipment	6 Months Ended
	Oct. 13, 2024
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment, net is summarized as follows: October 13, 2024 April 28, 2024 Leasehold improvements 84,933 84,747 Furniture, fixtures, and equipment 50,397 50,355 Building and building improvements 7,000 7,000 Finance lease 300 — Software 97 18 Construction in progress 11,212 9,557 Total cost 153,939 151,677 Less: accumulated depreciation (76,674) (71,662) Property and equipment, net 77,265 80,015 During the twelve and twenty-four weeks ended October 13, 2024, the Company capitalized interest expense of $105 and $211, respectively, into construction in progress. Construction in progress relates to new locations under construction.

Debt

Debt	6 Months Ended
	Oct. 13, 2024
Debt Disclosure [Abstract]
Debt	Debt Long-term notes payable consists of the following: October 13, 2024 April 28, 2024 PPP and SBA loans $ 500 $ 500 Term loans 35,560 34,300 Equipment loan 15,881 16,500 Senior notes 61,372 53,430 Finance obligations 5,649 6,124 Other 360 74 Less: unamortized debt issuance costs and discounts (35,216) (35,433) Total 84,106 75,495 Less: current portion of long-term notes payable (6,659) (4,818) Long-term notes payable $ 77,447 $ 70,677 PPP & SBA Loans In April 2020, the Company executed a loan pursuant to the Paycheck Protection Program (“PPP”) loans, which was administered by the Small Business Association (“SBA”) under the CARES Act and the PPP Flexibility Act of 2020, for $7,725. During the fiscal year ended April 25, 2021, the Company executed three PPP loans totaling $3,265. Each PPP loan matures two years after issuance. The interest rate on each PPP loan is 1.0% annually. As authorized by the provisions of the CARES Act, the Company applied for and received forgiveness of a portion of the PPP loans during the fiscal year ended April 30, 2023. As such, the Company recorded a gain on the extinguishment of debt for $8,458, which includes accrued interest during the fiscal year ended April 30, 2023. As of October 13, 2024 and April 28, 2024, the principal outstanding related to these loans was approximately $500. Term Loans On March 7, 2023, the Company entered into a term loan facility (the “Silverview Facility”), consisting of two tranches and detachable warrants (see Note 10), with Silverview Credit Partners LP (“Silverview”) for $35,000 (the “Silverview Tranche 1 Loan”) that matures on June 7, 2027. As part of the transaction, the Company repaid $5,598 of term loans with Live Oak Banking Company. The interest rate on the term loan is 15%, which is payable monthly, and is collateralized by a first lien security interest in the assets of the business. At each six-month interval beginning in March of fiscal year 2024, the Company began repaying the principal amount. In March 2024 and September 2024, the Company made principal payments of $700 and $740, respectively. The Silverview Facility provides for a second tranche (the “Silverview Tranche 2 Loan”) that allows the Company to draw an additional $12,500 solely during the Silverview Tranche 2 Loan availability period which ends on the earlier of September 7, 2024, or the date on which obligations shall become due and payable in full per the loan agreement. Under the Silverview Tranche 2 Loan, the Company can borrow $2,500 per draw for each of five new store openings ($12,500 in aggregate). On August 1, 2023, the Company and Silverview entered into an agreement whereby the Company agreed to grant Silverview warrants to purchase shares of the Company’s Common Stock issuable and exercisable by Silverview if the Company obtains additional funding under the Silverview Tranche 2 Loan. Simultaneously, the Company amended and restated its existing warrant agreement (see Note 10). The Company determined that the amendment was treated as a debt modification and accordingly, no gain or loss was recognized. On July 27, 2023, September 29, 2023, October 20, 2023 and December 29, 2023 the Company received $1,000, $1,500, $5,000 and $5,000 respectively, in additional debt proceeds from Silverview under the Silverview Tranche 2 Loan to fund expansion, which bear interest at 15% and will be payable in full on June 7, 2027. Upon the issuance of each Silverview Tranche 2 Loan, the Company reduced the Silverview Tranche 2 Loan commitment asset for the proportional amount received and presents the amounts as a debt issuance costs and a reduction of the borrowing proceeds (i.e., a debt discount). As of April 28, 2024, the Company had drawn the total $12,500 available under the Silverview Tranche 2 Loan. As such, all of the remaining loan commitment asset of $1,203 has been reclassified to debt discount of $559 and debt issuance costs of $644. On September 3, 2024, the Company and Silverview entered into the Sixth Amendment (the “Silverview Sixth Amendment”) to the Silverview Facility dated March 7, 2023. The Sixth Amendment provides for a third tranche loan (the “Silverview Tranche 3 Loan”) of $2,000, made on September 3, 2024 and matures on June 7, 2027. The Silverview Tranche 3 Loan bears an interest rate per annum equal to 15%. Additionally, the Company agreed to grant Silverview warrants to purchase 29,292 shares of the Company’s Class A Common Stock (see Note 10). The Company determined that the amendment was treated as a debt modification and accordingly, no gain or loss was recognized. The Company recorded a debt discount of $177. As of October 13, 2024, and April 28, 2024, the principal outstanding related to the Silverview Facility was $35,560 and $34,300, respectively. As of April 28, 2024, the Company incurred debt issuance costs and discounts, net of amortization, of $4,400, of which $1,510 was debt issuance costs, $2,890 was debt discount on the consolidated balance sheets. As of October 13, 2024, the Company has recorded debt issuance costs and discounts, net of amortization, of $3,782, of which $1,273 was debt issuance costs and $2,509 was debt discount on the condensed consolidated balance sheets. Equipment Loan On April 19, 2023, the Company entered into a subordinated equipment loan (the “Granite Creek Facility”) of $11,500 and detachable warrants (see Note 10) with Granite Creek Capital Partners LLC (“Granite Creek”) that matures on April 19, 2028. The interest rate on the loan is 12% and is payable monthly. The Granite Creek Facility is collateralized by the specific furniture, fixture and equipment assets of the business. The outstanding principal is repayable in quarterly installments equal to $431 on the last day of each calendar quarter commencing on September 30, 2024. On July 27, 2023, the Company restated the term loan agreement with Granite Creek, to provide for $5,000 in additional debt financing and the issuance of additional detachable warrants (see Note 10) for development of new locations that matures on April 19, 2028, bears interest at 12%, and is repayable in quarterly installments of $188 beginning September 30, 2024. The Company determined that the amendment was treated as a debt modification and accordingly, no gain or loss was recognized. On September 30, 2024, the Company made a principal payment of $619. As of April 28, 2024, the Company incurred debt issuance costs and discounts, net of amortization, of $3,285, of which $60 was recorded as debt issuance costs and $3,225 was recorded as a debt discount on the consolidated balance sheets. As of October 13, 2024, the Company has recorded debt issuance costs and discounts, net of amortization, of $2,899, of which $53 was debt issuance costs and $2,846 was debt discount on the condensed consolidated balance sheets. Senior Notes On December 29, 2023, in connection with the Reverse Recapitalization (see Note 2), the Company entered into a definitive loan agreement with Oaktree Fund Administration, LLC, as agent, (“Oaktree”) under which the Company issued Senior Secured Notes (“Senior Notes”) to Oaktree, which mature in five years on December 29, 2028, and detachable warrants (see Note 10). The principal payment is due at maturity. The loan agreement provides for Senior Notes of up to $90,000 in the aggregate to be funded in two tranches as follows (a) an initial loan of $50,000 (“Oaktree Tranche 1 Loan”), which closed on December 29, 2023 in connection with the closing of the Business Combination, and (b) an additional $40,000 of Senior Notes is to be funded at the sole discretion of Oaktree no earlier than nine months and no later than 12 months after the Business Combination closing date (“Oaktree Tranche 2 Loan”). The Company will use the proceeds from the Oaktree Tranche 1 Loan for general business purposes, including the settlement of Business Combination related transaction costs and to fund expansion efforts. A condition to the funding of the Oaktree Tranche 2 Term Loan is that the Company shall use the proceeds to repay all outstanding amounts under the Silverview Facility. Interest on the Oaktree Tranche 1 Loan accrues on a daily basis calculated based on a 360-day year at a rate per annum equal to (i) 12.5% payable in arrears, at Pinstripes’ option either in cash or in kind (subject to certain procedures and conditions); provided that the interest payable in respect of any period following December 31, 2024, interest under this clause (i) will be required to be paid solely in cash, plus (ii) 7.5% payable quarterly in arrears, at Pinstripes’ option, either in cash or in kind (subject to certain procedures and conditions). On each payment interest date, the Company will increase the principal amount based upon the contractual rate and assume the value of the payment in kind is equal to the amount accrued. The effective interest rate of the original debt will incorporate the paid-in-kind (PIK) interest in the computation of the effective interest rate as an assumed cash flow on each payment date. As of October 13, 2024 and April 28, 2024, the Company recorded $8,732 and $3,430, respectively, of accrued PIK interest in long-term notes payable in the condensed consolidated balance sheets. The obligations of the Company under the Oaktree Tranche 1 Loan are unconditionally guaranteed (the “Guarantees”) by Pinstripes and certain other subsidiaries of Pinstripes (collectively, the “Guarantors”). The obligations under the Oaktree Tranche 1 Loan and the Guarantees are secured by a second lien security interest in substantially all assets of the Guarantors, subordinate to the first lien security interests of the other senior secured lenders (Silverview and Granite Creek) of Pinstripes, and including a pledge of the equity of the Company. Any prepayment of the Oaktree Tranche 1 Loan prior to its maturity date will be subject to a customary “make-whole” premium calculated using a discount rate equal to the yield on comparable Treasury securities plus 50 basis points. The Oaktree Tranche 2 Loan presents a written option to Oaktree to issue an additional $40,000 of funding at Oaktree’s sole discretion. The Company determined the written option for the Oaktree Tranche 2 Loan requires recognition as a liability and to be remeasured at fair value at the end of each reporting period. On December 29, 2023, the written option was initially recognized at its issuance date fair value of $1,773. During the fiscal year ended April 28, 2024, the Company recorded a gain for the change in fair value of the written option in the amount of $761, which was presented within the change in fair value of warrant liabilities and other in the consolidated financial statements of operations. As of April 28, 2024, the fair value of the written option was $1,012. During the twelve and twenty-four weeks ended October 13, 2024, the Company recorded a loss for the change in fair value of the written option in the amount of $1,357 and $720, respectively, which is presented within the change in fair value of warrant liabilities and other on the unaudited condensed consolidated financial statements of operations. As of October 13, 2024, the fair value of the written option was $1,732. On September 3, 2024, the Company and Oaktree entered into the First Amendment (the “Oaktree First Amendment”) to the Senior Notes. The Oaktree First Amendment provides, among things, that: (i) the Oaktree Lenders have the option, in their discretion to fund additional loans under the Oaktree Tranche 2 Loan of up to $50,000 in any number of separate drawings (rather than $40,000 in a single tranche), (ii) the Company is obligated to grant additional Oaktree Tranche 2 Warrants on any closing of a Oaktree Tranche 2 Loan (see Note 10) and (iii) the proceeds received under Tranche 2 Loan no longer have to be used to repay all outstanding amounts under the Silverview Facility. In connection with the closing of the Oaktree First Amendment, Oaktree funded an Oaktree Tranche 2 Loan in the amount of $3,000 and agreed to grant an Oaktree Tranche 2 Warrant exercisable for 174,750 shares of the Company’s Class A Common Stock (see Note 10). The principal payment of the Oaktree Tranche 2 Loan is due at maturity on December 29, 2028. Interest on the Oaktree Tranche 2 Loan accrues on a daily basis calculated based on a 360-day year at a rate per annum equal to (i) 12.5% payable quarterly in arrears, at the Company’s option either in cash or in kind (subject to certain procedures and conditions) prior to December 31, 2024, and thereafter solely in cash, plus (ii) 7.5% payable quarterly in arrears, at the Company’s option, either in cash or in kind (subject to certain procedures and conditions) at all times. The Company determined that the amendment was treated as a debt modification and accordingly, no gain or loss was recognized. As a result of the debt modification, the Company recorded debt discount of $831. As of April 28, 2024, the Company has recorded debt issuance costs and discounts, net of amortization, of $27,747, of which $496 was debt issuance costs and $27,251 was debt discount on the consolidated balance sheets. As of October 13, 2024, the Company has recorded debt issuance costs and discounts, net of amortization, of $28,535, of which $468 was debt issuance costs and $28,067 was debt discount on the condensed consolidated balance sheets. Convertible Notes On June 4, 2021, the Company entered into two convertible note agreements for $5,000 in the aggregate. The convertible notes accrue interest at 1.07% annually and mature on June 4, 2025. Holders of the convertible notes had the right, at their option, to convert all of the outstanding principal and accrued interest to shares of Legacy Pinstripes Common Stock equal to the quotient of (i) the outstanding principal on the convertible note divided by (ii) the conversion price of $10 per share. In connection with the closing of the Business Combination, the convertible note holders elected to convert all of the outstanding $5,000 principal balance and the $137 of accrued unpaid interest to approximately 5,000 shares of Legacy Pinstripes Common Stock. With the election to convert all of the outstanding principal and accrued interest at 1.07%, the holder of the note forfeited additional interest of $890. Finance Obligations In 2011, the Company entered into a failed sale leaseback at its Northbrook, Illinois location. The Company sold the building, fixtures and certain personal property and assigned the ground lease to a new lessor. The Company received $7,000 from the transaction, which was accounted for as a financing obligation with repayment terms of 15 years. The obligation is repaid in monthly installment payments, which includes principal and interest at an 8.15% annual rate. As of October 13, 2024 and April 28, 2024, the principal outstanding was $3,175 and $3,460, respectively. During fiscal year 2024, the Company entered into agreements to pay for its bowling equipment for four locations through a long-term payment plan. The Company will pay approximately $2,805 for the equipment, which was accounted for as a financing obligation with a repayment term of five years. The obligation is repaid in monthly installment payments, which includes principal and interest at a 10% annual rate. As of October 13, 2024 and April 28, 2024, the principal outstanding was $2,473 and $2,664, respectively. Debt Covenants On December 29, 2023, the Silverview and Granite Creek Facilities were amended in connection with the entry into the Oaktree loan and Oaktree’s entry into intercreditor agreements with each of Silverview and Granite Creek. The Silverview Facility and Granite Creek Facility were amended to align the measurement periods for the financial covenants of all three loan agreements, inclusive of Oaktree, and to provide for the Company’s guarantee of their obligations under each of the Silverview Facility and Granite Creek Facility. The Senior Notes, along with the amended Silverview Facility and Granite Creek Facility, require the Company to maintain a minimum specified total net leverage ratio. The Company’s loan agreements contain events of default with respect to, among other things, default in the payment of principal when due or the payment of interest, fees and other amounts due thereunder after a specific grace period, material misrepresentations and failure to comply with covenants. The Guarantors are subject to negative covenants restricting the activities of the Guarantors, including, without limitation, limitations on: dispositions, mergers or acquisitions, incurring indebtedness or liens, paying dividends or redeeming stock or making other distributions, making certain investments and engaging in certain other business transactions. The first covenant measurement period is ending on January 6, 2025. As of October 13, 2024, the Guarantors do not expect to be in compliance with the debt covenants as of the first measurement date based on their current obligations and liquidity. The Company could seek a waiver if necessary. Liquidity and Going Concern Under ASC 205, Presentation of Financial Statements , the Company is required to consider and evaluate whether there is substantial doubt that it has the ability to meet its obligations within one year from the financial statement issuance date. This assessment also includes the Company’s consideration of any management plans to alleviate such doubts. The Company has reported negative working capital as of October 13, 2024 and April 28, 2024, and had losses from operations and cash used in operating activities for the twenty-four weeks ended October 13, 2024 and for the fiscal year ended April 28, 2024. The Company’s ability to continue as a going concern is dependent upon it generating sufficient cash from operations over the next year from the date of the issuance of these financial statements. The Company believes that its current earnings projections, which include full year results for the stores that opened during the fiscal year ended April 28, 2024 and new store openings, raise substantial doubt on the Company’s ability to continue as a going concern and the Company’s ability to meet its current obligations, including for capital expenditures, lease obligations and continued operations as they become due within one year from the financial statement issuance date. To alleviate the conditions that raise substantial doubt about the Company’s ability to continue as a going concern, management is exploring additional financing and a capital raise by the end of the fiscal third quarter. While the Company has historically been successful in raising outside capital, there can be no assurance the Company will be able to continue to obtain outside capital in the future or do so on terms that are acceptable to the Company. The Company continues to implement meaningful cost reductions, receive committed lessor tenant allowances and renegotiate leases and other agreements with favorable terms. Due to these uncertainties, management concluded that substantial doubt exists with respect to the Company’s ability to continue as a going concern within one year from the financial statement issuance date. The accompanying unaudited condensed consolidated financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates that the Company will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying unaudited condensed consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties. Fair Value The fair value of long-term notes payable, including current maturities, as of October 13, 2024 and April 28, 2024 is approximately $87,349 and $71,061, respectively, and estimated using Level 3 inputs.

Income Taxes

Income Taxes	6 Months Ended
	Oct. 13, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s full pretax loss for the twelve and twenty-four weeks ended October 13, 2024 and October 15, 2023 was from U.S. domestic operations. The Company’s effective tax rate (“ETR”) from continuing operations was (0.7)% and (0.7)% for the twelve and twenty-four weeks ended October 13, 2024, respectively, and (0.8)% and 0.0% for the twelve and twenty-four weeks ended October 15, 2023, respectively, and consists of state income taxes. There were no significant discrete items recorded for the twelve and twenty-four weeks ended October 13, 2024 and October 15, 2023, respectively.

Leases

Leases	6 Months Ended
	Oct. 13, 2024
Leases [Abstract]
Leases	Leases The Company leases various assets, including real estate, retail buildings, restaurant equipment and office equipment. The Company has non-cancelable operating leases expiring at various times through 2036. In June 2023, the Company entered into a lease amendment for one location that resulted in a lease modification in accordance with Accounting Standards Codification 842, Leases (ASC 842), under which the Company received an abatement of $4,673 and deferral of previously unpaid rent of $4,500. The modification of the lease increased the lease liability by $2,678, decreased accrued occupancy costs by $9,173, and decreased the right-of-use asset, which resulted in a gain of $3,281 that is included as a reduction in the Company’s store occupancy costs, excluding depreciation, on the unaudited condensed consolidated statements of operations for the twenty-four weeks ended October 15, 2023. As of October 13, 2024, the Company has entered into additional operating leases with $57,782 in aggregate future fixed lease payments related to new locations, which have not yet commenced. As of October 13, 2024, the Company did not have control of the underlying properties. The components of lease expense are as follows: Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Operating lease cost $ 3,997 $ 3,545 $ 9,248 $ 3,877 Variable lease cost 1,274 1,355 2,703 2,569 Short term lease cost 219 215 415 302 Total lease cost $ 5,490 $ 5,115 $ 12,366 $ 6,748 The operating lease costs, except pre-opening costs of $442 and $589 for the twelve and twenty-four weeks ended October 13, 2024, respectively, and $394 and $1,003 for the twelve and twenty-four weeks ended October 15, 2023, respectively, are included within store occupancy costs on the unaudited condensed consolidated statements of operations.

Redeemable Convertible Preferre

Redeemable Convertible Preferred Stock	6 Months Ended
	Oct. 13, 2024
Temporary Equity Disclosure [Abstract]
Redeemable Convertible Preferred Stock	Redeemable Convertible Preferred Stock As of October 15, 2023, Legacy Pinstripes had nine classes of preferred stock: Series A, B, C, D, E, F, G, H and I (collectively, the “Preferred Stock”) and a total of 11,054,593 issued and outstanding with a carrying value of $75,262 and a liquidation preference of $114,663. On December 29, 2023, upon the closing of the Business Combination, Series A through Series H converted into New Pinstripes shares of Class A Common Stock based on the Exchange Ratio of approximately 1.8486 and Series I converted into Class A Common Stock based on the Series I Exchange Ratio of approximately 2.5, inclusive of accrued Series I dividends (see Note 2). The changes in the balance of the Preferred Stock included in the mezzanine equity for the fiscal year ended April 28, 2024 as follows: Balance as of April 30. 2023 Issuance of Redeemable Convertible Preferred Stock, net Remeasurement to Redemption Amount Accretion of Cumulative Dividends Conversion in connection with the Reverse Recapitalization Balance as of April 28, 2024 Series A $ 1,151 $ — $ — $ — $ (1,151) $ — Series B 930 — — — (930) — Series C 300 — — — (300) — Series D 10,340 — — — (10,340) — Series E 2,207 — — — (2,207) — Series F 27,290 — — — (27,290) — Series G 3,550 — — — (3,550) — Series H 7,700 — — — (7,700) — Series I — 19,843 1,423 878 (22,144) — Total $ 53,468 $ 19,843 $ 1,423 $ 878 $ (75,612) $ —

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Oct. 13, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Legacy Pinstripes’s 2008 Equity Incentive Plan (the “Plan”) provided for the issuance of 2,900,000 shares of Legacy Pinstripes Common Stock in the form of an option award or restricted stock award to eligible employees and directors. On October 19, 2023, the Board of Directors of Legacy Pinstripes approved a new equity incentive plan, the 2023 Stock Option Plan (the “2023 Plan”), which provided for the issuance of 1,500,000 shares of Legacy Pinstripes Common Stock in the form of options awards to eligible employees and directors. On December 29, 2023, in connection with the closing of the Business Combination, the Board of Directors of the Company approved a 2023 Omnibus Equity Incentive Plan (the “2023 Omnibus Plan”), which provides for the issuances of up to 12,900,000 shares of Class A Common Stock in the form of option awards, stock appreciation rights, restricted stock awards (“RSAs”), restricted stock unit awards (“RSUs”) and performance awards to eligible employees and directors. The number of shares of Class A Common Stock available for issuance under the 2023 Omnibus Plan will be subject to an annual increase on the first day of each fiscal year of the Company beginning April 29, 2024, equal to the lesser of (i) 15% of the aggregate number of shares outstanding on the final day of the immediately preceding fiscal year on a fully diluted basis (inclusive of all outstanding awards granted pursuant to the 2023 Omnibus Plan as of such last day and, if applicable, all outstanding purchase rights pursuant to an employee stock purchase plan maintained by the Company as of such last day) and (ii) any such smaller number of shares as is determined by the Board. Option awards vest 20% at the end of each year over 5 years and expire 10 years from the date of grant, or generally within 90 days of employee termination. RSAs vest one third at the end of each year over three years and expire 10 years from the date of grant, or generally within 90 days of employee termination. There were no stock appreciation rights or performance awards outstanding as of October 13, 2024 and April 28, 2024. Stock Options We recorded compensation expense related to stock options of $275 and $592 for the twelve and twenty-four weeks ended October 13, 2024, respectively, and $220 and $361 for the twelve and twenty-four weeks ended October 15, 2023, respectively. A summary of equity classified option activity for the twenty-four weeks ended October 13, 2024 is as follows: Number of Options Weighted-average Exercise Price Weighted-average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding at April 28, 2024 4,691,701 $ 6.76 6.43 $ — Granted 52,424 2.97 Exercised — — $ — Cancelled or expired (447,001) 6.10 Outstanding at October 13, 2024 4,297,124 $ 6.79 5.94 $ — Exercisable at October 13, 2024 2,579,939 $ 4.90 4.36 The unrecognized expense related to our stock option plan totaled approximately $5,042 as of October 13, 2024 and will be expensed over a weighted average period 1.85 years. Restricted Stock Awards We recorded compensation expense related to RSAs of $72 and $129 for the twelve and twenty-four weeks ended October 13, 2024, respectively. We did not grant RSAs prior to fiscal 2025. A summary of equity classified RSA activity for the twenty-four weeks ended October 13, 2024 is as follows: Shares Weighted-Average Grant Date Fair Value Per Share Unvested at April 28, 2024 — — Granted 394,512 2.66 Forfeited (18,000) 2.52 Vested — — Unvested at October 13, 2024 376,512 2.66 The unrecognized expense related to our Restricted Stock Awards totaled approximately $864 as of October 13, 2024 and will be expensed over a weighted average period 1.65 years. Restricted Stock Unit Awards On January 19, 2024, non-employee directors received a restricted stock unit award, with the number of shares issued to the director determined by dividing $125,000 by the average of the high and low price of Pinstripes’ common stock on the grant date. The awards vest one year from the grant date. We recorded compensation expense related to RSUs of $172 and $344 for the twelve and twenty-four weeks ended October 13, 2024, respectively. We did not grant RSUs prior to the fourth quarter of fiscal 2024. As of October 13, 2024, 172,806 RSUs were outstanding with a weighted average grant date fair value of $4.34 per share. None were vested as of October 13, 2024. The unrecognized expense related to our RSUs totaled approximately $199 as of October 13, 2024 and will be expensed over a weighted average period 0.27 years.

Warrants

Warrants	6 Months Ended
	Oct. 13, 2024
Equity [Abstract]
Warrants	Warrants In fiscal year 2023, the Company issued 267,000 warrants to Silverview (the “Silverview Warrants”), recorded at fair value in additional paid-in capital within the condensed consolidated balance sheets of $1,712, net of issuance costs. Upon surrender of these warrants, the holder was entitled to purchase one share of Legacy Pinstripes Common Stock at an exercise price of $0.01. Furthermore, in fiscal year 2023, the Company issued 7,500 warrants to another service provider with an exercise price of $10 per share. On August 1, 2023, the Company and Silverview amended and restated the Silverview warrant agreement to correct the number of shares of common stock Silverview was entitled to subscribe and purchase from 258,303 to 162,946. A separate warrant agreement for 8,697 warrants of the 267,000 issued in fiscal year 2024 was not amended and the warrants remained issued. Under the term loan agreement, the Company was contractually obligated to issue a specified number of warrants to Silverview in the event the Company elected to exercise its right to obtain additional funding from Silverview under the term loan agreement. Therefore, the remaining warrants were considered contingently issuable and the contingency was satisfied when a draw on Silverview Tranche 2 Loan occurred. For accounting purposes, all 267,000 warrants were still considered issued and outstanding. As a result of the amended and restated warrant agreement with Silverview, the Company determined the contingently issuable warrants required recognition as a liability. The contingently issuable warrants were reclassified at their current fair value on August 1, 2023. When the contingently issuable warrants’ contingency was satisfied, the respective warrant shares were considered indexed to the Company’s common stock and qualified for equity classification under the derivative scope exception provided by Accounting Standards Codification, Derivatives and Hedging (ASC 815). Upon the satisfaction of the issuance contingency, the Company shall (i) reclassify the respective warrant shares to equity and (ii) recognize any previous gains or losses in fair value through earnings during the period the shares were classified as a liability. On August 1, 2023, the Company issued 7,629 warrant shares to Silverview in exchange for $1,000 in funding drawn under the Silverview Tranche 2 Loan (see Note 5). As of August 1, 2023, 179,272 shares were considered issued warrants and 87,728 shares were considered contingently issuable warrants. On September 29, 2023, the Company issued 11,443 warrants in exchange for $1,500 in funding drawn under the Silverview Tranche 2 Loan. As the contingency was satisfied for these warrants, $173 was reclassed from the warrant liability to additional paid-in-capital. On October 20, 2023, the Company issued 38,143 warrants in exchange for $5,000 in funding drawn under the Silverview Tranche 2 Loan. As the contingency was satisfied for these warrants, $524 was reclassed from the warrant liability to additional paid-in-capital. On December 29, 2023, the Company issued 38,142 warrants in exchange for $5,000 in funding drawn under the Silverview Tranche 2 Loan. As the contingency was satisfied for these warrants, $415 was reclassed from the warrant liability to additional paid-in-capital. In April 2023 and July 2023, the Company also issued 111,619 and 48,530 warrants, respectively, to Granite Creek in connection with its equipment loan agreement (the “Granite Creek Warrants”). Granite Creek had the right to require Legacy Pinstripes to pay cash to repurchase all or any portion of the warrants or the shares of Common Stock issued under the warrants. The Company determined these warrants required liability classification in accordance with Accounting Standards Codification 480, Distinguishing Liabilities from Equity (ASC 480), and as a result, recorded a warrant liability. On December 4, 2023, Granite Creek exercised their warrants at a par value of $0.01. The Company de-recognized the warrant liability of $2,202. In determining the fair value of the Granite Creek warrants and Silverview contingently issuable warrants as of the measurement date, the Company utilized the intrinsic value valuation method using level 3 inputs consisting of the fair value of common stock as of the measurement date less the exercise price of $0.01 for Silverview and less the exercise price of $0.001 for the Granite Creek warrants. In connection with the Reverse Recapitalization, the holders of Legacy Pinstripes’ warrants elected to convert all outstanding warrants to shares of New Pinstripes Common Stock on a cashless basis (see Note 2). As of April 28, 2024, there were no outstanding Legacy Pinstripes warrants. On September 3, 2024, the Company amended the Silverview Facility (see Note 5) and the Company agreed to grant Silverview warrants to purchase 29,292 shares of the Company’s Class A Common Stock (the “Silverview Tranche 3 Warrants”), at an exercise price of $0.01 per share. The Silverview Tranche 3 Warrants are indexed to the Company’s common stock and qualified for equity classification under the derivative scope exception provided by ASC 815. The Silverview Tranche 3 Warrants were recorded at fair value in additional paid-in-capital for $67. In connection with Banyan’s initial public offering, Banyan issued (i) 12,075,000 public warrants (“Public Warrants”) and 11,910,000 private placement warrants (“Private Warrants”). On December 29, 2023, in connection with the Reverse Capitalization, the Company effectively issued an aggregate of 23,985,000 warrants to purchase an equal number of shares of Class A Common Stock, representing the 12,075,000 Public Warrants and 11,910,000 Private Warrants. The Public Warrants and Private Warrants remained unexercised and were issued and outstanding as of October 13, 2024. The Public Warrants and Private Warrants meet the definition of a derivative instrument, requiring liability classification, and are measured at fair value on a recurring basis with the change in fair value recognized in the Company’s unaudited condensed consolidated statements of operations. The fair value of the Public Warrants is measured by the Company’s publicly traded warrant price. In determining the fair value of the Private Warrants, the Company utilizes the Cox-Rubenstein-Ross binomial lattice model using Level 3 inputs consisting of the fair value of the Public Warrants as of the measurement and implied equity volatility. On the December 29, 2023 issuance date, the Company recorded a warrant liability for the Public Warrants and Private Warrants in the fair value amounts of $4,456 and $25,368, respectively. During the twelve and twenty-four weeks ended October 13, 2024, the Company recognized a gain for the change in fair value of the Public Warrants and Private Warrants in the amounts of $966 and $1,932, respectively, and $2,132 and $3,204, respectively. The Public Warrants are exercisable 30 days after consummation of the Reverse Recapitalization if, and only if, there is a current registration statement in effect with respect to the shares of Common Stock underlying the Public Warrants, and expire five years from the consummation of the Reverse Recapitalization, or earlier upon redemption or liquidation. The redemption of the Public Warrants is as follows: Redemption of Public Warrants when the price per Common Stock equals or exceeds $18.00. Once the Public Warrants become exercisable, the Company may redeem the Public Warrants: • in whole and not in part; • at a price of $0.01 per warrant; • upon not less than 30 days prior written notice of redemption to each warrant holder; and • if, and only if, the closing price of the underlying Common Stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three If and when the Public Warrants become redeemable by the Company, it may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Public Warrants when the price per Common Stock equals or exceeds $10.00 . Once the Public Warrants become exercisable, the Company may redeem the Public Warrants: • in whole and not in part; • at $0.10 per warrant; • upon a minimum of 30 days prior written notice of redemption provided that holders will be able to exercise the Public Warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the fair market value of the underlying Common Stock; • if, and only if, the last reported sale price of the underlying Common Stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like) for any 20 trading days within the 30-trading day period ending three trading days before the Company send the notice of redemption to the holders; and • if the closing price of the underlying Common Stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the holders is less than $18.00 per share, the Private Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above. The Private Warrants are identical to the Public Warrants with the exception that the underlying shares of Common Stock issuable upon exercise of Private Warrants are not transferable, assignable or saleable, until 30 days after the consummation of the Reverse Recapitalization, subject to certain limited exceptions. Additionally, the holders have the right to exercise the Private Warrants on a cashless basis and are entitled certain registration rights. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company in all Public Warrant redemption scenarios described above, on the same basis as the Public Warrants. In connection with the Reverse Recapitalization, the Company entered into a loan agreement with Oaktree (see Note 5). In connection with the closing of the Oaktree Tranche 1 Loan, Oaktree was granted fully detachable warrants exercisable for an aggregate 2,500,000 shares of Class A Common Stock, at an exercise price of $0.01 per share (“Oaktree Tranche 1 Warrant s ”). In the event that the volume-weighted average price (“VWAP”) per share of the Company’s Class A Common Stock during the period commencing on the 91 st day after the closing of the Business Combination and ending 90 days thereafter is less than $8.00 per share, the Company shall grant to Oaktree a warrant to purchase Common Stock for 187,500 shares of Class A Common Stock, at an exercise price of $0.01 per share (“Additional Oaktree Tranche 1 Warrants”). If the VWAP is less than $6.00 during the same period, the Company shall instead grant to Oaktree a warrant to purchase common stock for 412,500 shares of Class A Common Stock, at an exercise price of $0.01 per share (“Additional Oaktree Tranche 1 Warrants”). Therefore, the Additional Oaktree Tranche 1 Warrants are considered contingently issuable and the contingency is satisfied when the Class A Common Stock meets the contingency requirements above. During the period commencing on the 91st day after the closing of the Business Combination and ending 90 days thereafter, the VWAP was less than $6.00 and as such, the Company legally issued the Additional Oaktree Tranche 1 Warrants for 412,500 shares of Class A Common Stock on June 27, 2024 at an exercise price of $0.01 per share. As the Additional Oaktree Tranche 1 Warrants were considered issued and outstanding for accounting purposes on December 29, 2023 when the Senior Notes were issued, there is no accounting recognition at the legal issuance date when the issuance contingency was resolved. In the event the Oaktree Tranche 2 Loan is funded, Oaktree will be granted additional warrants exercisable for an aggregate amount of 1,650,000 shares of Class A Common Stock, at an exercise price of $0.01 per share (“Oaktree Tranche 2 Warrants” (collectively, the Oaktree Tranche 1 Warrants, Additional Oaktree Tranche 1 Warrants and Tranche 2 Warrants are referred to as the “Oaktree Warrants”). In the event that the VWAP per share of Class A Common Stock during the period commencing the 91 st day after the closing of the Oaktree Tranche 2 Loan and ending 90 days thereafter is less than $6.00 per share, Oaktree will instead be granted Oaktree Tranche 2 Warrants exercisable for an aggregate of 1,900,000 shares of Class A Common Stock, at an exercise price of $0.01 per share. The Oaktree Warrants will be exercisable on a cashless basis and the Company has agreed to register for the resale of the shares of Class A Common Stock underling the Oaktree Warrants. With the closing of the Oaktree First Amendment (see Note 5), the Company is obligated to grant Additional Oaktree Tranche 2 Warrants on any closing of a Oaktree Tranche 2 Loan equal to the product of 2,912,500 (1,012,500 warrants incremental to the original 1,900,000 warrants) multiplied by the quotient of (A) the total amount funded on such Tranche 2 Loan closing date by (B) $50,000 (rather than a single additional warrant exercisable for 1,900,000 shares), and the Company shall issue any Additional Oaktree Tranche 2 Warrant in a form consistent with the Oaktree Warrant Amendment described below. In connection with the Oaktree First Amendment (see Note 5), the Company and Oaktree entered into Amendment No. 1 to the Class A Common Stock Purchase Warrants (the “Oaktree Warrant Amendment”), which eliminates the one-year lock-up restriction (subject to limited exceptions) that had existed in respect of the 2,912,500 shares of the Company’s Class A Common Stock issuable upon exercise of warrants (Oaktree Tranche 1 Warrants) issued by the Company to Oaktree in connection with the funding of the original Oaktree Tranche 1 Loan under the Oaktree Loan Agreement (as well as the same restriction that had been applicable to the transfer of the warrants themselves). The Company determined the Oaktree Tranche 1 Warrants meet the equity classification guidance. Upon surrender of these equity-classified warrants, the holder is entitled to purchase one share of Class A Common Stock at $0.01 per share. The equity classified warrants expire on the 10-year anniversary of the Reverse Recapitalization. Under the Oaktree loan agreement, the Company is contractually obligated to issue a specified number of warrants to Oaktree based on the scenarios above. Therefore, the Oaktree Tranche 2 Warrants are considered contingently issuable and the contingency is satisfied when Oaktree exercises its written option on the Oaktree Tranche 2 Loan and the Class A Common Stock meets the contingency requirements above. When the contingently issuable warrants’ contingency is satisfied, the respective shares underlying these warrants will be considered indexed to the Class A Common Stock and qualify for equity classification under the derivative scope exception provided by ASC 815. Upon the satisfaction of the issuance contingency, the Company will (i) reclassify the respective warrant shares to equity and (ii) recognize any previous gains or losses in fair value through earnings during the period the shares were classified as a liability. As a result of the amended warrant agreement with Oaktree, the Company determined the contingently issuable warrants required recognition as a liability. The 1,900,000 of contingently issuable warrants were reclassified from additional paid-in capital to a liability at their current fair value of $1,864 on September 3, 2024. The additional 1,012,500 warrants were liability-classified on September 3, 2024 at their fair value of $859. In connection with the closing of the Oaktree First Amendment, the Company issued 174,750 warrants in exchange for $3,000 in funding under the Oaktree Tranche 2 Loan. As the contingency was satisfied for these warrants, $401 was reclassed from warrant liabilities to additional paid-in-capital on the condensed consolidated balance sheets. As of October 13, 2024, outstanding warrants were as follows: Number of Warrants Weighted-Average Exercise Price Outstanding at April 28, 2024 28,797,500 $ 9.58 Granted 1,041,792 0.01 Expired — — Exercised — $ — Outstanding as of October 13, 2024 29,839,292 $ 9.25 The Company remeasures the liability-classified warrants to fair value at each reporting period. During the twenty-four weeks ended October 13, 2024, the change in the fair value was as follows: Warrant liabilities as of April 28, 2024 $ 5,411 Change in fair value (2,038) Warrant liabilities as of July 21, 2024 $ 3,373 Reclassification of liability-classified warrants 1,864 Incremental shares granted to Oaktree 859 Issuance of contingently issuable shares (401) Change in fair value (4,928) Warrant liabilities as of October 13, 2024 $ 766 The change in fair value of the liability-classified warrants are reported in the gain on change in fair value of warrant liabilities and other on the unaudited condensed consolidated statements of operations. Upon surrender of the Public and Private Warrants, the holder is entitled to purchase one share of Class A Common Stock at $11.50 per share. The outstanding Public and Private Warrants expire on the five-year anniversary of the closing of the Reverse Recapitalization. Upon surrender of the Oaktree Tranche 2 Warrants, the holder is entitled to purchase one share of Class A Common Stock at $0.01 per share. The outstanding Oaktree Tranche 2 Warrants expire ten years from the issuance date of the warrant.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Oct. 13, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share Basic net loss per share is calculated using the two-class method required for companies with participating securities. The two-class method is an earnings allocation formula under which the Company treats participating securities as having rights to earnings that otherwise would have been available to common shareholders. The Company considers the Redeemable Convertible Preferred Stock to be participating securities as the holders are entitled to receive dividends on an as-if converted basis equal to common stock. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of common stock outstanding, including issued but unexercised pre-funded warrants outstanding, during the respective periods. As the contingently issuable warrants are contingent upon additional funding under the Oaktree Tranche 2 Loan being received, they have not been included in the calculation of basic net loss per share. Diluted net loss per share is calculated using the more dilutive of either the treasury stock, and if-converted method, as applicable, or the two-class method assuming the participating security is not converted. The Company did not declare any common stock dividends in the periods presented. The following tables provide the calculation of basic and diluted net loss per share of common stock for the twelve and twenty-four weeks ended October 13, 2024 and October 15, 2023: Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Numerator: Net loss (9,310) (7,283) (19,316) (10,329) Cumulative unpaid dividends on Series I redeemable convertible preferred stock — (394) — (528) Change in redemption amount of redeemable convertible preferred stock — — — (1,423) Net loss attributable to common stockholders (9,310) (7,677) (19,316) (12,280) Earnings allocated to participating securities — — — — Net loss available to common stockholders, basic and diluted (9,310) (7,677) (19,316) (12,280) Denominator: Weighted average common shares outstanding, basic 43,099,877 12,066,454 42,905,215 12,094,424 Dilutive awards outstanding — — — — Weighted average common shares outstanding, diluted 43,099,877 12,066,454 42,905,215 12,094,424 Loss per share: Basic $ (0.22) $ (0.64) $ (0.45) $ (1.02) Diluted $ (0.22) $ (0.64) (0.45) $ (1.02) The following table conveys the number of shares that may be dilutive potential common shares in the future. The holders of these shares do not have a contractual obligation to share in the Company’s losses. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted loss per share (in thousands): Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Stock options 4,297 5,269 4,297 5,269 Restricted stock units 173 — 173 — Restricted stock awards 377 — 377 — Warrants 23,985 194 23,985 194 Contingently issuable warrants 2,738 141 2,738 141 Preferred Stock (as converted to common stock) — 24,312 — 24,312 Convertible debt (as converted to common stock) — 948 — 948

Commitment and Contingencies

Commitment and Contingencies	6 Months Ended
	Oct. 13, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company is subject to certain legal proceedings and claims that arise in the ordinary course of business, including claims alleging violations of federal and state law regarding workplace and employment matters, discrimination, slip-and-fall and other customer-related incidents, and similar matters. While it is not feasible to predict the outcome of all proceedings and exposures with certainty, management believes that, except as set forth below, their ultimate disposition should not have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. On November 6, 2023, Riveron Consulting, LLC filed a lawsuit against the Company in the District Court of the 95th Judicial District of Dallas County, Texas for breach of contract and failure to receive compensation for services rendered. The complaint seeks monetary relief for services rendered and attorneys’ fees. As of October 13, 2024 and April 28, 2024, the Company has accrued a liability of $464 within accounts payable in the condensed consolidated balance sheets as this amount represents the probable and reasonably estimable cost to resolve this matter.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Oct. 13, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions For the twelve and twenty-four weeks ended October 13, 2024 and October 15, 2023, a company owned by an individual with ownership in common shares of the Company, and who is a relative of an executive officer, performed design services and supplied furniture, fixtures and equipment for existing and new locations under construction of $14 and $676, and $10 and $21, respectively. As of October 13, 2024 and April 28, 2024, $1,519 and $1,918 due to this related party is included in accounts payable within the condensed consolidated balance sheets, respectively.

Subsequent Events

Subsequent Events	6 Months Ended
	Oct. 13, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company evaluated subsequent events through November 26, 2024, the date of issuance of these financial statements, and determined there were no additional items that required further disclosure or recognition.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				5 Months Ended	6 Months Ended
	Oct. 13, 2024	Jul. 21, 2024	Oct. 15, 2023	Jul. 23, 2023	Oct. 15, 2023	Oct. 13, 2024
Pay vs Performance Disclosure
Net (loss) income	$ (9,310)	$ (10,006)	$ (7,283)	$ (3,046)	$ (10,329)	$ (19,316)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Oct. 13, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Nature of Business and Basis _2

Nature of Business and Basis of Presentation (Policies)	6 Months Ended
	Oct. 13, 2024
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its directly and indirectly wholly owned subsidiaries: Pinstripes, Inc., Pinstripes at Prairiefire, Inc., Pinstripes Illinois, LLC, and Pinstripes, Hillsdale, LLC. All intercompany accounts and transactions have been eliminated in consolidation.
Fiscal Years	Fiscal Years The Company’s fiscal year consists of 52/53-weeks ending on the last Sunday in April. The fiscal year ended April 28, 2024 contained 52 weeks. In a 52-week fiscal year, the first, second and third fiscal quarters each contain twelve weeks and the fourth fiscal quarter contains sixteen weeks. In a 53-week fiscal year, the first, second and third fiscal quarters each contain twelve weeks and the fourth fiscal quarter contains seventeen weeks.
Interim Financial Statements	Interim Financial Statements The Company’s financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) in the United States for interim financial information as prescribed by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all the information and notes required by GAAP for complete financial statements. In the opinion of management, these financial statements contain all adjustments, consisting of normal recurring accruals, necessary to present fairly the financial position, results of operations and cash flows for the periods indicated. Certain information and footnote disclosures normally included in annual financial statements presented in accordance with GAAP have been omitted pursuant to rules and regulations of the SEC. Due to the seasonality of the Company’s business, results for any interim financial period are not necessarily indicative of the results that may be achieved for a full fiscal year. In addition, quarterly results of operations may be impacted by the timing and amount of sales and costs associated with opening new locations. These interim unaudited condensed consolidated financial statements do not represent complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended April 28, 2024, included in the 2024 Annual Report, which was filed with the SEC on June 28, 2024.
Use of Estimates	Use of Estimates The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.
Cash and cash equivalents	Cash and cash equivalents
Revenue	Food and beverage revenues and recreation revenues are recognized when payment is tendered at the point of sale as the performance obligation has been satisfied. Food and beverage revenues include the sale of food and beverage products. Recreation revenues include bowling and bocce sales. Revenues are recognized net of discounts and taxes. Event deposits received from guests are deferred and recognized as revenue when the event is held. Event deposits received from customers in advance are included in amounts due to customers in the condensed consolidated balance sheets in the amounts of $7,739 as of October 13, 2024 and $6,640 as of April 28, 2024. The Company sells gift cards, which do not have expiration dates, and does not deduct non-usage fees from outstanding gift card balances. Gift card sales are initially recorded by the Company as a liability and subsequently recognized as revenue upon redemption by the customer. For unredeemed gift cards that the Company expects to be entitled to breakage and for which there is no legal obligation to remit the unredeemed gift card balances to the relevant jurisdictions, the Company recognizes expected breakage as revenue in proportion to the pattern of redemption by the customers. The determination of the gift card breakage is based on the Company’s specific historical redemption patterns. The contract liability related to our gift cards is included in amounts due to customers in the condensed consolidated balance sheets in the amounts of $1,743 as of October 13, 2024 and $1,993 as of April 28, 2024. The components of gift card revenue were as follows: Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Redemptions, net of discounts $ 422 $ 369 $ 1,036 $ 883 Breakage $ 103 $ 103 $ 240 $ 245 Gift card revenue, net $ 525 $ 472 $ 1,276 $ 1,128 Revenues are reported net of sales tax collected from customers. Sales tax collected is included in other accrued liabilities on the condensed consolidated balance sheets until the taxes are remitted to the appropriate taxing authorities.
Pre-opening costs	Pre-opening costs
Recently adopted and issued accounting standards	Recently adopted and issued accounting standards In November 2023, the FASB issued Update 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures". This Update applies to all public entities that are required to report segment information in accordance with Topic 280. The amendments in this Update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in this Update do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The new standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The standard should be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adopting this new standard. In December 2023, the FASB issued Update 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures". This Update applies to all entities that are subject to Topic 740. The amendments in this Update improve income tax disclosures primarily related to the rate reconciliation and income taxes paid information as well as the effectiveness of certain other income tax disclosures. The new standard is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The standard should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the impact of adopting this new standard. Management reviewed the accounting pronouncements that became effective for the second quarter of fiscal year 2024 and determined that either they were not applicable, or they did not have a material impact on the condensed consolidated financial statements. Management also reviewed the recently issued accounting pronouncements to be adopted in future periods and determined that they are not expected to have a material impact on the condensed consolidated financial statements.

Nature of Business and Basis _3

Nature of Business and Basis of Presentation (Tables)	6 Months Ended
	Oct. 13, 2024
Accounting Policies [Abstract]
Schedule of Components of Revenue	The components of gift card revenue were as follows: Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Redemptions, net of discounts $ 422 $ 369 $ 1,036 $ 883 Breakage $ 103 $ 103 $ 240 $ 245 Gift card revenue, net $ 525 $ 472 $ 1,276 $ 1,128

Reverse Recapitalization (Table

Reverse Recapitalization (Tables)	6 Months Ended
	Oct. 13, 2024
Reverse Recapitalization [Abstract]
Schedule Of Reverse Recapitalization	The number of shares of New Pinstripes Class A Common Stock issued immediately following the consummation of the Reverse Capitalization was as follows: Shares Legacy Pinstripes stockholders (1) 33,449,433 Banyan stockholders (2) 3,697,203 Series I Investors 2,721,400 Other 50,000 Total shares of New Pinstripes Class A Common Stock outstanding immediately following the Reverse Recapitalization 39,918,036 (1) Excludes the 5,000,000 Target Earnout Shares and the 4,000,000 EBITDA Earnout shares subject to forfeiture if the achievement of certain targets is not met. (2) Includes the 1,018,750 shares of New Pinstripes Class A Common Stock to certain investors in Banyan who agreed not to redeem their respective shares of Banyan Class A Common Stock in connection with Banyan’s extension meeting held on April 21, 2023 and excludes the 1,830,000 Sponsor Earnout Shares subject to forfeiture if the achievement of certain targets is not met.

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Oct. 13, 2024
Inventory Disclosure [Abstract]
Schedule of Inventory	Inventories consist of the following: October 13, 2024 April 28, 2024 Beverage $ 606 $ 672 Food 254 277 Total $ 860 $ 949

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Oct. 13, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment, net is summarized as follows: October 13, 2024 April 28, 2024 Leasehold improvements 84,933 84,747 Furniture, fixtures, and equipment 50,397 50,355 Building and building improvements 7,000 7,000 Finance lease 300 — Software 97 18 Construction in progress 11,212 9,557 Total cost 153,939 151,677 Less: accumulated depreciation (76,674) (71,662) Property and equipment, net 77,265 80,015

Debt (Tables)

Debt (Tables)	6 Months Ended
	Oct. 13, 2024
Debt Disclosure [Abstract]
Schedule of Long-Term Debt Instruments	Long-term notes payable consists of the following: October 13, 2024 April 28, 2024 PPP and SBA loans $ 500 $ 500 Term loans 35,560 34,300 Equipment loan 15,881 16,500 Senior notes 61,372 53,430 Finance obligations 5,649 6,124 Other 360 74 Less: unamortized debt issuance costs and discounts (35,216) (35,433) Total 84,106 75,495 Less: current portion of long-term notes payable (6,659) (4,818) Long-term notes payable $ 77,447 $ 70,677

Leases (Tables)

Leases (Tables)	6 Months Ended
	Oct. 13, 2024
Leases [Abstract]
Schedule of Components of Lease Expense	The components of lease expense are as follows: Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Operating lease cost $ 3,997 $ 3,545 $ 9,248 $ 3,877 Variable lease cost 1,274 1,355 2,703 2,569 Short term lease cost 219 215 415 302 Total lease cost $ 5,490 $ 5,115 $ 12,366 $ 6,748

Redeemable Convertible Prefer_2

Redeemable Convertible Preferred Stock (Tables)	6 Months Ended
	Oct. 13, 2024
Temporary Equity Disclosure [Abstract]
Schedule of Temporary Equity	The changes in the balance of the Preferred Stock included in the mezzanine equity for the fiscal year ended April 28, 2024 as follows: Balance as of April 30. 2023 Issuance of Redeemable Convertible Preferred Stock, net Remeasurement to Redemption Amount Accretion of Cumulative Dividends Conversion in connection with the Reverse Recapitalization Balance as of April 28, 2024 Series A $ 1,151 $ — $ — $ — $ (1,151) $ — Series B 930 — — — (930) — Series C 300 — — — (300) — Series D 10,340 — — — (10,340) — Series E 2,207 — — — (2,207) — Series F 27,290 — — — (27,290) — Series G 3,550 — — — (3,550) — Series H 7,700 — — — (7,700) — Series I — 19,843 1,423 878 (22,144) — Total $ 53,468 $ 19,843 $ 1,423 $ 878 $ (75,612) $ —

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Oct. 13, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Option Activity	A summary of equity classified option activity for the twenty-four weeks ended October 13, 2024 is as follows: Number of Options Weighted-average Exercise Price Weighted-average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding at April 28, 2024 4,691,701 $ 6.76 6.43 $ — Granted 52,424 2.97 Exercised — — $ — Cancelled or expired (447,001) 6.10 Outstanding at October 13, 2024 4,297,124 $ 6.79 5.94 $ — Exercisable at October 13, 2024 2,579,939 $ 4.90 4.36
Nonvested Restricted Stock Shares Activity	A summary of equity classified RSA activity for the twenty-four weeks ended October 13, 2024 is as follows: Shares Weighted-Average Grant Date Fair Value Per Share Unvested at April 28, 2024 — — Granted 394,512 2.66 Forfeited (18,000) 2.52 Vested — — Unvested at October 13, 2024 376,512 2.66

Warrants (Tables)

Warrants (Tables)	6 Months Ended
	Oct. 13, 2024
Equity [Abstract]
Schedule of Warrants	As of October 13, 2024, outstanding warrants were as follows: Number of Warrants Weighted-Average Exercise Price Outstanding at April 28, 2024 28,797,500 $ 9.58 Granted 1,041,792 0.01 Expired — — Exercised — $ — Outstanding as of October 13, 2024 29,839,292 $ 9.25 The Company remeasures the liability-classified warrants to fair value at each reporting period. During the twenty-four weeks ended October 13, 2024, the change in the fair value was as follows: Warrant liabilities as of April 28, 2024 $ 5,411 Change in fair value (2,038) Warrant liabilities as of July 21, 2024 $ 3,373 Reclassification of liability-classified warrants 1,864 Incremental shares granted to Oaktree 859 Issuance of contingently issuable shares (401) Change in fair value (4,928) Warrant liabilities as of October 13, 2024 $ 766

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Oct. 13, 2024
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Loss Per Share of Common Stock	The following tables provide the calculation of basic and diluted net loss per share of common stock for the twelve and twenty-four weeks ended October 13, 2024 and October 15, 2023: Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Numerator: Net loss (9,310) (7,283) (19,316) (10,329) Cumulative unpaid dividends on Series I redeemable convertible preferred stock — (394) — (528) Change in redemption amount of redeemable convertible preferred stock — — — (1,423) Net loss attributable to common stockholders (9,310) (7,677) (19,316) (12,280) Earnings allocated to participating securities — — — — Net loss available to common stockholders, basic and diluted (9,310) (7,677) (19,316) (12,280) Denominator: Weighted average common shares outstanding, basic 43,099,877 12,066,454 42,905,215 12,094,424 Dilutive awards outstanding — — — — Weighted average common shares outstanding, diluted 43,099,877 12,066,454 42,905,215 12,094,424 Loss per share: Basic $ (0.22) $ (0.64) $ (0.45) $ (1.02) Diluted $ (0.22) $ (0.64) (0.45) $ (1.02)
Schedule of Antidilutive Securities	The following table conveys the number of shares that may be dilutive potential common shares in the future. The holders of these shares do not have a contractual obligation to share in the Company’s losses. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted loss per share (in thousands): Twelve Weeks Ended Twenty-Four Weeks Ended October 13, 2024 October 15, 2023 October 13, 2024 October 15, 2023 Stock options 4,297 5,269 4,297 5,269 Restricted stock units 173 — 173 — Restricted stock awards 377 — 377 — Warrants 23,985 194 23,985 194 Contingently issuable warrants 2,738 141 2,738 141 Preferred Stock (as converted to common stock) — 24,312 — 24,312 Convertible debt (as converted to common stock) — 948 — 948

Nature of Business and Basis _4

Nature of Business and Basis of Presentation - Narrative (Details) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended
	Oct. 13, 2024 USD ($) state location	Oct. 15, 2023 USD ($)	Oct. 15, 2023 USD ($)	Oct. 13, 2024 USD ($) segment state location	Apr. 28, 2024 USD ($)
Accounting Policies [Abstract]
Number of locations | location	17			17
Number of states | state	10			10
Number of operating segments | segment				1
Number of reportable segments | segment				1
Credit and debit card receivables	$ 1,294			$ 1,294	$ 1,624
Deposits	7,739			7,739	$ 6,640
Pre-opening expenses	$ 1,568	$ 3,026	$ 5,304	$ 2,574

Nature of Business and Basis _5

Nature of Business and Basis of Presentation - Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended
	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024	Apr. 28, 2024
Disaggregation of Revenue [Line Items]
Total revenue	$ 26,482	$ 24,623	$ 50,364	$ 57,077
Gift card revenue, net
Disaggregation of Revenue [Line Items]
Contract liability	1,743			1,743	$ 1,993
Total revenue	525	472	1,128	1,276
Redemptions, net of discounts
Disaggregation of Revenue [Line Items]
Total revenue	422	369	883	1,036
Breakage
Disaggregation of Revenue [Line Items]
Total revenue	$ 103	$ 103	$ 245	$ 240

Nature of Business and Basis _6

Nature of Business and Basis of Presentation - Common and Preferred Stock (Details) - $ / shares	Oct. 13, 2024	Apr. 28, 2024	Dec. 29, 2023	Dec. 28, 2023	Apr. 30, 2023
Class of Stock [Line Items]
Common stock, shares authorized	430,000,000	430,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001			$ 0.0001
Common stock, shares issued (in shares)	40,087,785	40,087,785		17,422,009
Common stock, shares outstanding (in shares)	40,087,785	40,087,785	39,918,036	17,422,009
Preferred stock, shares authorized	10,000,000
Preferred stock, par value, (in dollars per share)	$ 0.0001
Preferred stock, shares issued (in shares)	0			11,089,695
Preferred stock, shares outstanding (in shares)	0			11,089,695
Class A Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	400,000,000
Common stock, par value (in dollars per share)	$ 0.0001
Common stock, shares issued (in shares)	40,087,785
Common stock, shares outstanding (in shares)	40,087,785
Class B-1 Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	10,000,000
Common stock, par value (in dollars per share)	$ 0.0001
Common stock, shares issued (in shares)	0
Common stock, shares outstanding (in shares)	0
Class B-2 Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	10,000,000
Common stock, par value (in dollars per share)	$ 0.0001
Common stock, shares issued (in shares)	0
Common stock, shares outstanding (in shares)	0
Class B-3 Common Stock
Class of Stock [Line Items]
Common stock, shares authorized	10,000,000
Common stock, par value (in dollars per share)	$ 0.0001
Common stock, shares issued (in shares)	0
Common stock, shares outstanding (in shares)	0

Reverse Recapitalization - Narr

Reverse Recapitalization - Narrative (Details) - USD ($)			3 Months Ended		5 Months Ended	6 Months Ended	12 Months Ended
	Dec. 29, 2023	Dec. 28, 2023	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024	Apr. 28, 2024	Apr. 30, 2023
Schedule of Reverse Recapitalization [Line Items]
Preferred stock, shares issued (in shares)		11,089,695	0			0
Preferred stock, shares outstanding (in shares)		11,089,695	0			0
Warrants outstanding (in shares)		354,436	29,839,292			29,839,292	28,797,500
Sale of private placement warrants (in shares)		354,436
Shares issued upon conversion (in shares)						5,000
Common stock, shares issued (in shares)		17,422,009	40,087,785			40,087,785	40,087,785
Common stock, shares outstanding (in shares)	39,918,036	17,422,009	40,087,785			40,087,785	40,087,785
Exercise price of warrant (in dollars per share)			$ 9.25			$ 9.25	$ 9.58
Transaction costs for registration statements			$ 25,000			$ 76,000	$ 635,000
Transaction costs adjustment			(50,000)
Transaction costs, reverse capitalization				$ 1,367,000	$ 4,126,000		24,317,000
Payments for transaction costs			10,000			10,000
Prepaid transaction costs			940,000			940,000	940,000
Taxes payable			$ 53,000			$ 53,000	$ 53,000
Common stock, par value (in dollars per share)			$ 0.0001			$ 0.0001	$ 0.0001	$ 0.0001
Oaktree Warrants
Schedule of Reverse Recapitalization [Line Items]
Sale of private placement warrants (in shares)	2,500,000
Exercise price of warrant (in dollars per share)	$ 0.01
Senior notes
Schedule of Reverse Recapitalization [Line Items]
Face amount	$ 90,000,000
Tranche 1 Loan | Senior notes
Schedule of Reverse Recapitalization [Line Items]
Shares issued upon conversion (in shares)	2,500,000
Face amount	$ 50,000,000
Exercise price of warrant (in dollars per share)	$ 0.01
Banyan Acquisition Corporation
Schedule of Reverse Recapitalization [Line Items]
Sale of private placement warrants (in shares)	23,985,000
Series I Investors
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	2,721,400
Legacy Pinstripes Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	33,449,433
Options vested and expected to vest (in shares)		2,722,593
Options exercisable (in shares)		5,032,434
Third Party
Schedule of Reverse Recapitalization [Line Items]
Transaction costs		$ 500,000
Banyan Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	3,697,203
Series I Convertible Preferred Stock And Convertible Preferred Stock, Settled For Unpaid Dividends | Series I Investors
Schedule of Reverse Recapitalization [Line Items]
Shares issued (in shares)		885,750
Series I Convertible Preferred Stock
Schedule of Reverse Recapitalization [Line Items]
Preferred stock, shares outstanding (in shares)		850,648
Convertible Preferred Stock, Settled For Unpaid Dividends
Schedule of Reverse Recapitalization [Line Items]
Preferred stock, shares outstanding (in shares)		35,102
Legacy Pinstripes Common Stock
Schedule of Reverse Recapitalization [Line Items]
Shares issued (in shares)		11,089,695
Shares issued upon conversion (in shares)		500,000
Class A Common Stock
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)			40,087,785			40,087,785
Common stock, shares outstanding (in shares)			40,087,785			40,087,785
Common stock, par value (in dollars per share)			$ 0.0001			$ 0.0001
Class A Common Stock | Scenario 1
Schedule of Reverse Recapitalization [Line Items]
Shares issued (in shares)		32,206,458
Conversion ratio	1.8486
Class A Common Stock | Scenario 2
Schedule of Reverse Recapitalization [Line Items]
Shares issued (in shares)		2,214,375
Conversion ratio		2.5
Class A Common Stock | Banyan Acquisition Corporation
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)	1,485,000	3,665,000
Common stock, shares outstanding (in shares)	1,485,000	3,665,000
Shares forfeited (in shares)		2,768,750
Class A Common Stock | Series I Investors
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)		507,025
Class A Common Stock | Banyan Acquisition Corporation
Schedule of Reverse Recapitalization [Line Items]
Conversion ratio	2.5
Class A Common Stock | Banyan Redeemable Class A Common Stock Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)		32,203
Class A Common Stock | Legacy Pinstripes Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)		1,242,975
Class A Common Stock | Certain Investors, Banyan
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)		1,018,750
New Pinstripes Common Stock | Banyan Class A Common Stock Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)		3,665,000
New Pinstripes Common Stock | Third Party
Schedule of Reverse Recapitalization [Line Items]
Issuance of common stock as payment for legacy pinstripes transaction costs incurred in connection with the reverse recapitalization (in shares)		50,000
Redeemable Class A Common Stock | Banyan Acquisition Corporation
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)		32,203
Common stock, shares outstanding (in shares)		32,203
Class B common stock | Banyan Acquisition Corporation
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)	345,000
Common stock, shares outstanding (in shares)	345,000
Sponsor Earnout Shares | Banyan Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)	1,830,000
Target Earnout Shares | Legacy Pinstripes Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)	5,000,000
EBITDA Earnout Shares | Legacy Pinstripes Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)	4,000,000

Reverse Recapitalization - Sche

Reverse Recapitalization - Schedule of Reverse Recapitalization (Details) - shares	Oct. 13, 2024	Apr. 28, 2024	Dec. 29, 2023	Dec. 28, 2023
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	40,087,785	40,087,785	39,918,036	17,422,009
Common stock, shares issued (in shares)	40,087,785	40,087,785		17,422,009
Class A Common Stock
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)	40,087,785
Common stock, shares issued (in shares)	40,087,785
Legacy Pinstripes Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)			33,449,433
Legacy Pinstripes Stockholders | Target Earnout Shares
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)			5,000,000
Legacy Pinstripes Stockholders | EBITDA Earnout Shares
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)			4,000,000
Legacy Pinstripes Stockholders | Class A Common Stock
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)				1,242,975
Banyan Stockholders
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)			3,697,203
Banyan Stockholders | Sponsor Earnout Shares
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)			1,830,000
Series I Investors
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)			2,721,400
Series I Investors | Class A Common Stock
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)				507,025
Other
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares outstanding (in shares)			50,000
Certain Investors, Banyan | Class A Common Stock
Schedule of Reverse Recapitalization [Line Items]
Common stock, shares issued (in shares)				1,018,750

Inventory (Details)

Inventory (Details) - USD ($) $ in Thousands	Oct. 13, 2024	Apr. 28, 2024
Inventory [Line Items]
Total	$ 860	$ 949
Beverage
Inventory [Line Items]
Total	606	672
Food
Inventory [Line Items]
Total	$ 254	$ 277

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Oct. 13, 2024	Oct. 13, 2024	Apr. 28, 2024
Property, Plant and Equipment [Line Items]
Total cost	$ 153,939	$ 153,939	$ 151,677
Less: accumulated depreciation	(76,674)	(76,674)	(71,662)
Property and equipment, net	77,265	77,265	80,015
Capitalized cost	105	211
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total cost	84,933	84,933	84,747
Furniture, fixtures, and equipment
Property, Plant and Equipment [Line Items]
Total cost	50,397	50,397	50,355
Building and building improvements
Property, Plant and Equipment [Line Items]
Total cost	7,000	7,000	7,000
Finance lease
Property, Plant and Equipment [Line Items]
Total cost	300	300	0
Software
Property, Plant and Equipment [Line Items]
Total cost	97	97	18
Construction in progress
Property, Plant and Equipment [Line Items]
Total cost	$ 11,212	$ 11,212	$ 9,557

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Oct. 13, 2024	Apr. 28, 2024
Debt Instrument [Line Items]
Less: unamortized debt issuance costs and discounts	$ (35,216)	$ (35,433)
Total	84,106	75,495
Less: current portion of long-term notes payable	(6,659)	(4,818)
Long-term notes payable	77,447	70,677
PPP and SBA loans
Debt Instrument [Line Items]
Long-term debt	500	500
Term loans
Debt Instrument [Line Items]
Long-term debt	35,560	34,300
Equipment loan
Debt Instrument [Line Items]
Long-term debt	15,881	16,500
Less: unamortized debt issuance costs and discounts	(2,899)	(3,285)
Senior notes
Debt Instrument [Line Items]
Long-term debt	61,372	53,430
Less: unamortized debt issuance costs and discounts	(28,535)	(27,747)
Finance obligations
Debt Instrument [Line Items]
Long-term debt	5,649	6,124
Total	2,473	2,664
Other
Debt Instrument [Line Items]
Long-term debt	$ 360	$ 74

Debt - PPP & SBA Loans (Narrati

Debt - PPP & SBA Loans (Narrative) (Details) $ in Thousands	12 Months Ended
	Apr. 30, 2023 USD ($)	Apr. 25, 2021 USD ($) debt_instrument	Oct. 13, 2024 USD ($)	Apr. 28, 2024 USD ($)	Jun. 04, 2021	Apr. 20, 2020 USD ($)
Debt Instrument [Line Items]
Interest rate					1.07%
PPP and SBA loans
Debt Instrument [Line Items]
Long-term debt			$ 500	$ 500
PPP and SBA loans | Paycheck Protection Program Loan
Debt Instrument [Line Items]
Face amount		$ 3,265				$ 7,725
Number of debt instruments | debt_instrument		3
Debt term		2 years
Interest rate		1%
Gain on extinguishment of debt	$ 8,458

Debt - Term Loans (Narrative) (

Debt - Term Loans (Narrative) (Details) $ in Thousands			1 Months Ended		12 Months Ended
	Sep. 03, 2024 USD ($) shares	Mar. 07, 2023 USD ($) store tranche	Sep. 30, 2024 USD ($)	Mar. 31, 2024 USD ($)	Apr. 28, 2024 USD ($)	Oct. 13, 2024 USD ($)	Dec. 29, 2023 USD ($)	Oct. 20, 2023 USD ($)	Sep. 29, 2023 USD ($)	Jul. 27, 2023 USD ($)	Jun. 04, 2021
Debt Instrument [Line Items]
Number of tranches | tranche		2
Interest rate											1.07%
Total					$ 75,495	$ 84,106
Unamortized debt issuance costs and discounts					35,433	35,216
Term loans
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 35,000
Interest rate		15%
Periodic payment			$ 740	$ 700
Term loans | Term Loan Facility, Tranche 2
Debt Instrument [Line Items]
Interest rate									15%
Additional borrowing capacity		$ 12,500					$ 5,000	$ 5,000	$ 1,500	$ 1,000
Additional borrowing capacity per draw		$ 2,500
Number of store openings | store		5
Proceeds from lines of credit					12,500
Loan commitment asset					1,203
Debt discount					559
Debt issuance costs, net of amortization					644
Total					34,300	35,560
Term loans | Silverview Tranche 3 Loan
Debt Instrument [Line Items]
Interest rate	15%
Proceeds from lines of credit	$ 2,000
Debt discount	$ 177
Warrants issued (in shares) | shares	29,292
Term loans | March 2023 Term Loan Facility
Debt Instrument [Line Items]
Debt discount					2,890
Debt issuance costs, net of amortization					1,510
Unamortized debt issuance costs and discounts					$ 4,400
Term loans | August 2023 Term Loan Facility
Debt Instrument [Line Items]
Debt discount						2,509
Debt issuance costs, net of amortization						1,273
Unamortized debt issuance costs and discounts						$ 3,782
Term loans | Live Oak Banking Company
Debt Instrument [Line Items]
Debt repaid		$ 5,598

Debt - Equipment Loan (Narrativ

Debt - Equipment Loan (Narrative) (Details) - USD ($) $ in Thousands			1 Months Ended
	Jul. 27, 2023	Apr. 19, 2023	Sep. 30, 2024	Oct. 13, 2024	Apr. 28, 2024	Jun. 04, 2021
Debt Instrument [Line Items]
Interest rate						1.07%
Unamortized debt issuance costs and discounts				$ 35,216	$ 35,433
Equipment loan
Debt Instrument [Line Items]
Face amount	$ 5,000	$ 11,500
Interest rate	12%	12%
Periodic payment	$ 188	$ 431
Periodic payment, principal			$ 619
Unamortized debt issuance costs and discounts				2,899	3,285
Debt issuance costs, net of amortization				53	60
Debt discount				$ 2,846	$ 3,225

Debt - Senior Notes (Narrative)

Debt - Senior Notes (Narrative) (Details)			3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 03, 2024 USD ($) shares	Dec. 29, 2023 USD ($) tranche	Oct. 13, 2024 USD ($)	Oct. 13, 2024 USD ($)	Apr. 28, 2024 USD ($)	Mar. 07, 2023 USD ($) tranche	Jun. 04, 2021
Debt Instrument [Line Items]
Number of tranches | tranche						2
Interest rate							1.07%
Unamortized debt issuance costs and discounts			$ 35,216,000	$ 35,216,000	$ 35,433,000
Senior notes
Debt Instrument [Line Items]
Debt term		5 years
Face amount		$ 90,000,000
Number of tranches | tranche		2
Interest rate		12.50%
Accrued interest			8,732,000	8,732,000	3,430,000
Unamortized debt issuance costs and discounts			28,535,000	28,535,000	27,747,000
Debt issuance costs, net of amortization			468,000	468,000	496,000
Debt discount			28,067,000	28,067,000	27,251,000
Senior notes | Scenario 1
Debt Instrument [Line Items]
Interest rate		7.50%
Senior notes | Tranche 1 Loan
Debt Instrument [Line Items]
Face amount		$ 50,000,000
Senior notes | Tranche 2 Loan
Debt Instrument [Line Items]
Face amount		$ 40,000,000
Variable spread		0.50%
Fair value of debt		$ 1,773,000	1,732,000	1,732,000	1,012,000
Gain (loss) on change in fair value			$ (1,357,000)	$ (720,000)	$ 761,000
Term loans
Debt Instrument [Line Items]
Maximum borrowing capacity						$ 35,000,000
Interest rate						15%
Term loans | Oaktree Tranche 2 Loan
Debt Instrument [Line Items]
Interest rate	12.50%
Proceeds from warrant issuances	$ 3,000,000
Warrants issued (in shares) | shares	174,750
Debt discount	$ 831,000
Term loans | Oaktree Tranche 2 Loan | Scenario 1
Debt Instrument [Line Items]
Interest rate	7.50%

Debt - Convertible Notes (Narra

Debt - Convertible Notes (Narrative) (Details) $ / shares in Units, $ in Thousands	6 Months Ended
	Oct. 13, 2024 USD ($) shares	Jun. 04, 2021 USD ($) debt_instrument $ / shares
Debt Instrument [Line Items]
Interest rate		1.07%
Shares issued upon conversion (in shares) | shares	5,000
Convertible Debt
Debt Instrument [Line Items]
Number of debt instruments | debt_instrument		2
Face amount		$ 5,000
Conversion price (in dollars per share) | $ / shares		$ 10
Accrued interest	$ 137
Forfeiture of accrued interest in connection with the conversion of long-term notes payable	$ 890

Debt - Finance Obligations (Nar

Debt - Finance Obligations (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Apr. 28, 2024	Dec. 31, 2011	Oct. 13, 2024	Jun. 04, 2021
Debt Instrument [Line Items]
Interest rate				1.07%
Debt outstanding	$ 75,495		$ 84,106
Finance obligations
Debt Instrument [Line Items]
Face amount	$ 2,805
Debt term	5 years
Interest rate	10%
Debt outstanding	$ 2,664		2,473
Finance obligations | Northbrook, Illinois Financing Obligation
Debt Instrument [Line Items]
Face amount		$ 7,000
Debt term		15 years
Interest rate		8.15%
Debt outstanding	$ 3,460		$ 3,175

Debt - Fair Value (Narrative) (

Debt - Fair Value (Narrative) (Details) - USD ($) $ in Thousands	Oct. 13, 2024	Apr. 28, 2024
Level 3 | Finance obligations
Debt Instrument [Line Items]
Fair value of debt	$ 87,349	$ 71,061

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		5 Months Ended	6 Months Ended
	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024
Income Tax Disclosure [Abstract]
Effective tax rate (in percent)	(0.70%)	(0.80%)	0%	(0.70%)

Leases (Narrative) (Details)

Leases (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		5 Months Ended	6 Months Ended
	Jun. 30, 2023	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024
Leases [Abstract]
Lease abatement	$ 4,673
Deferred rent	4,500
Increase in lease liability	2,678			$ (4,697)	$ (5,144)
Decrease in occupancy costs	9,173			4,210	(1,738)
Gain on lease modification	$ 3,281			3,281	0
Leases which have not yet commenced		$ 57,782			57,782
Operating lease expense		$ 442	$ 394	$ 1,003	$ 589

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended
	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024
Leases [Abstract]
Operating lease cost	$ 3,997	$ 3,545	$ 3,877	$ 9,248
Variable lease cost	1,274	1,355	2,569	2,703
Short term lease cost	219	215	302	415
Total lease cost	$ 5,490	$ 5,115	$ 6,748	$ 12,366

Redeemable Convertible Prefer_3

Redeemable Convertible Preferred Stock - Narrative (Details) - USD ($) $ in Thousands	Oct. 13, 2024	Jul. 21, 2024	Apr. 28, 2024	Dec. 29, 2023	Oct. 15, 2023		Jul. 23, 2023		Apr. 30, 2023
Temporary Equity [Line Items]
Temporary equity, shares outstanding (in shares)	0	0	0		20,989,710	[1]	20,851,710	[1]	18,863,090	[1]
Temporary equity, carrying amount	$ 0	$ 0	$ 0		$ 75,262		$ 73,488		$ 53,468
Preferred Stock (as converted to common stock)
Temporary Equity [Line Items]
Temporary equity, shares issued (in shares)					11,054,593
Temporary equity, shares outstanding (in shares)					11,054,593
Temporary equity, carrying amount					$ 75,262
Temporary equity, liquidation value					$ 114,663
Class A Common Stock | Scenario 1
Temporary Equity [Line Items]
Conversion ratio				1.8486
Class A Common Stock | Banyan Acquisition Corporation
Temporary Equity [Line Items]
Conversion ratio				2.5
[1]The number of shares of Redeemable Convertible Preferred Stock and Common Stock issued and outstanding prior to the Reverse Recapitalization have been retroactively adjusted by the Exchange Ratios to give effect to the Reverse Recapitalization. See Note 2.

Redeemable Convertible Prefer_4

Redeemable Convertible Preferred Stock - Schedule of Preferred Stock (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Oct. 15, 2023	Jul. 23, 2023	Apr. 28, 2024
Increase (Decrease) in Temporary Equity
Beginning balance	$ 73,488	$ 53,468	$ 53,468
Issuance of Redeemable Convertible Preferred Stock, net			19,843
Remeasurement to Redemption Amount		1,423	1,423
Accretion of Cumulative Dividends	394	134	878
Conversion in connection with the Reverse Recapitalization			(75,612)
Ending balance	75,262	73,488	0
Series A Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		1,151	1,151
Conversion in connection with the Reverse Recapitalization			(1,151)
Ending balance			0
Series B Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		930	930
Conversion in connection with the Reverse Recapitalization			(930)
Ending balance			0
Series C Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		300	300
Conversion in connection with the Reverse Recapitalization			(300)
Ending balance			0
Series D Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		10,340	10,340
Conversion in connection with the Reverse Recapitalization			(10,340)
Ending balance			0
Series E Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		2,207	2,207
Conversion in connection with the Reverse Recapitalization			(2,207)
Ending balance			0
Series F Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		27,290	27,290
Conversion in connection with the Reverse Recapitalization			(27,290)
Ending balance			0
Series G Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		3,550	3,550
Conversion in connection with the Reverse Recapitalization			(3,550)
Ending balance			0
Series H Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		7,700	7,700
Conversion in connection with the Reverse Recapitalization			(7,700)
Ending balance			0
Series I Preferred Stock
Increase (Decrease) in Temporary Equity
Beginning balance		0	0
Issuance of Redeemable Convertible Preferred Stock, net	$ 1,380	$ 18,463	19,843
Remeasurement to Redemption Amount			1,423
Accretion of Cumulative Dividends			878
Conversion in connection with the Reverse Recapitalization			(22,144)
Ending balance			$ 0

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands				3 Months Ended		5 Months Ended	6 Months Ended
	Apr. 29, 2024	Jan. 19, 2024	Oct. 19, 2023	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024	Apr. 28, 2024	Dec. 29, 2023	Dec. 31, 2008
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation						$ 361	$ 1,065
Unrecognized expense				$ 5,042			5,042
Stock options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation				275	$ 220	$ 361	$ 592
Unrecognized expense, period of recognition							1 year 10 months 6 days
Restricted stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation				72			$ 129
Unrecognized expense, period of recognition							1 year 7 months 24 days
Unrecognized expense				$ 864			$ 864
Instruments granted (in shares)							394,512,000
Outstanding (in shares)				376,512,000			376,512,000	0
Weighted average grant date fair value (in dollars per share)				$ 2.66			$ 2.66	$ 0
Vested (in shares)							0
Performance Shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Awards outstanding (in shares)				0			0	0
Stock Appreciation Rights (SARs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Awards outstanding (in shares)				0			0	0
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							1 year
Stock-based compensation				$ 172			$ 344
Unrecognized expense, period of recognition							3 months 7 days
Unrecognized expense				$ 199			$ 199
Value issued to non-employees		$ 125
Outstanding (in shares)				172,806,000			172,806,000
Weighted average grant date fair value (in dollars per share)				$ 4.34			$ 4.34
Vested (in shares)							0
2008 Equity Incentive Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares authorized (in shares)										2,900,000
2023 Stock Option Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares authorized (in shares)			1,500,000
2023 Omnibus Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares authorized (in shares)									12,900,000
Additional shares authorized, percent of shares outstanding	15%
2023 Omnibus Plan | Stock options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage			20%
Vesting period			5 years
Expiration period			10 years
Expiration period, employee termination			90 days
2023 Omnibus Plan | Restricted stock
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage			33.33%
Vesting period			3 years
Expiration period			10 years
Expiration period, employee termination			90 days

Stock-Based Compensation - Opti

Stock-Based Compensation - Options Outstanding (Details) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Oct. 13, 2024	Apr. 28, 2024
Number of Options
Outstanding, beginning balance (in shares)	4,691,701
Granted (in shares)	52,424
Exercised (in shares)	0
Cancelled or expired (in shares)	(447,001)
Outstanding, ending balance (in shares)	4,297,124	4,691,701
Exercisable (in shares)	2,579,939
Weighted-average Exercise Price
Outstanding, beginning balance (in dollars per share)	$ 6.76
Granted (in dollars per share)	2.97
Exercised (in dollars per share)	0
Cancelled or expired (in dollars per share)	6.10
Outstanding, ending balance (in dollars per share)	6.79	$ 6.76
Exercisable (in dollars per share)	$ 4.90
Weighted-average Remaining Contractual Term (in years)	5 years 11 months 8 days	6 years 5 months 4 days
Exercisable, Weighted-average Remaining Contractual Term (in years)	4 years 4 months 9 days
Aggregate Intrinsic Value (in thousands)	$ 0	$ 0
Aggregate Intrinsic Value (in thousands), Exercised	$ 0

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Awards (Details) - Restricted stock	6 Months Ended
	Oct. 13, 2024 $ / shares shares
Shares
Unvested, beginning balance (in shares) | shares	0
Granted (in shares) | shares	394,512,000
Forfeited (in shares) | shares	(18,000,000)
Vested (in shares) | shares	0
Unvested, ending balance (in shares) | shares	376,512,000
Weighted-Average Grant Date Fair Value Per Share
Unvested, beginning balance (in dollars per share) | $ / shares	$ 0
Granted (in dollars per share) | $ / shares	2.66
Forfeited (in dollars per share) | $ / shares	2.52
Vested (in dollars per share) | $ / shares	0
Unvested, ending balance (in dollars per share) | $ / shares	$ 2.66

Warrants - Narrative (Details)

Warrants - Narrative (Details)

3 Months Ended

5 Months Ended

6 Months Ended

Sep. 03, 2024 USD ($) $ / shares shares

Jun. 27, 2024 $ / shares shares

Dec. 29, 2023 USD ($) $ / shares shares

Oct. 20, 2023 USD ($) shares

Sep. 29, 2023 USD ($) shares

Aug. 01, 2023 USD ($) shares

Oct. 13, 2024 USD ($) $ / shares

Jul. 21, 2024 USD ($)

Oct. 15, 2023 USD ($)

Oct. 15, 2023 USD ($)

Oct. 13, 2024 USD ($) d $ / shares shares

Apr. 28, 2024 USD ($) $ / shares

Dec. 28, 2023 shares

Dec. 04, 2023 USD ($) $ / shares

Jul. 31, 2023 $ / shares shares

Apr. 30, 2023 USD ($) $ / shares shares

Jan. 24, 2022 shares

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 9.25

$ 9.25

$ 9.58

Sale of private placement warrants (in shares)

354,436

Issuance of warrants | $

$ 67,000

$ 173,000

Gain on change in fair value of warrant liabilities and other | $

(3,573,000)

(1,759,000)

$ (1,350,000)

$ (6,248,000)

Shares issued upon conversion (in shares)

5,000

Granted (in shares)

1,041,792

Reclassification of liability-classified warrants | $

$ (1,864,000)

$ (1,834,000)

$ 0

$ 1,864,000

Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 11.50

$ 11.50

Issuance of warrants | $

$ 401,000

$ 401,000

Warrants outstanding | $

766,000

$ 3,373,000

$ 766,000

$ 5,411,000

Gain on change in fair value of warrant liabilities and other | $

$ (4,928,000)

$ (2,038,000)

Expiration period

5 years

5 years

Reclassification of liability-classified warrants | $

$ 1,864,000

$ 1,864,000

Banyan Acquisition Corporation

Class of Warrant or Right [Line Items]

Sale of private placement warrants (in shares)

23,985,000

Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination

30 days

Senior notes

Class of Warrant or Right [Line Items]

Face amount | $

$ 90,000,000

Term Loan, Tranche 2 | Term loans

Class of Warrant or Right [Line Items]

Proceeds from warrant issuances | $

$ 5,000,000

$ 5,000,000

$ 1,500,000

$ 1,000,000

Term Loan, Tranche 2 | Senior notes

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.01

Shares issued upon conversion (in shares)

1,650,000

Silverview Tranche 3 Loan | Term loans

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.01

Proceeds from warrant issuances | $

$ 2,000,000

Issuance of warrants | $

$ 67,000

Warrants issued (in shares)

29,292

Tranche 1 Loan | Senior notes

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.01

Shares issued upon conversion (in shares)

2,500,000

Face amount | $

$ 50,000,000

Oaktree Tranche 2 Loan | Term loans

Class of Warrant or Right [Line Items]

Proceeds from warrant issuances | $

$ 3,000,000

Warrants issued (in shares)

174,750

Granted (in shares)

174,750

Tranche 2 Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.01

Sale of private placement warrants (in shares)

38,142

38,143

11,443

Issuance of warrants | $

$ 415,000

$ 524,000

$ 173,000

Trigger price (in dollars per share) | $ / shares

$ 6

Granted (in shares)

1,900,000

1,900,000

Public Warrants

Class of Warrant or Right [Line Items]

Warrants outstanding | $

$ 4,456,000

Gain on change in fair value of warrant liabilities and other | $

$ 966,000

$ 2,132,000

Exercisable term

30 days

Expiration period

5 years

5 years

Public Warrants | Banyan Acquisition Corporation

Class of Warrant or Right [Line Items]

Sale of private placement warrants (in shares)

12,075,000

Private Placement Warrants

Class of Warrant or Right [Line Items]

Warrants outstanding | $

$ 25,368,000

Gain on change in fair value of warrant liabilities and other | $

$ 1,932,000

$ 3,204,000

Private Placement Warrants | Banyan Acquisition Corporation | Private Placement

Class of Warrant or Right [Line Items]

Sale of private placement warrants (in shares)

11,910,000

Redemption Of Warrant Price Per Share Equals Or Exceeds 18.00 | Banyan Acquisition Corporation | Public Warrants

Class of Warrant or Right [Line Items]

Price per shares of common stock (in dollars per share) | $ / shares

$ 18

$ 18

Redemption price per public warrant (in dollars per share) | $ / shares

$ 0.01

Minimum threshold written notice period for redemption of public warrants

30 days

Threshold trading days for redemption of public warrants

20 days

Class of warrant or right redemption of warrants or rights threshold trading days before sending notice of redemption of warrants

3 days

Redemption Of Warrant Price Per Share Equals Or Exceeds 10.00 | Banyan Acquisition Corporation | Public Warrants

Class of Warrant or Right [Line Items]

Price per shares of common stock (in dollars per share) | $ / shares

$ 10

$ 10

Redemption price per public warrant (in dollars per share) | $ / shares

$ 0.10

Minimum threshold written notice period for redemption of public warrants

30 days

Threshold trading days for redemption of public warrants

20 days

Threshold consecutive trading days for redemption of public warrants | d

30

Contingently Issuable Tranche 1 Warrants | Warrant, Scenario 1

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.01

Trigger price (in dollars per share) | $ / shares

$ 8

Granted (in shares)

187,500

Contingently Issuable Tranche 1 Warrants | Warrant, Scenario 2

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.01

Trigger price (in dollars per share) | $ / shares

$ 6

$ 6

Granted (in shares)

412,500

412,500

Additional Oaktree Tranche 2 Warrants

Class of Warrant or Right [Line Items]

Granted (in shares)

2,912,500

Additional Oaktree Tranche 2 Warrants, Incremental

Class of Warrant or Right [Line Items]

Warrants outstanding | $

$ 859,000

Granted (in shares)

1,012,500

Tranche 1 Warrants

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.01

Expiration period

10 years

Silverview Credit Partners LP

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.01

$ 0.01

Sale of private placement warrants (in shares)

7,629

258,303

267,000

Warrants outstanding | $

$ 1,712,000

Silverview Credit Partners LP | Amended Warrants

Class of Warrant or Right [Line Items]

Sale of private placement warrants (in shares)

162,946

Silverview Credit Partners LP | Warrants Not Amended

Class of Warrant or Right [Line Items]

Sale of private placement warrants (in shares)

8,697

Silverview Credit Partners LP | Issued Warrants

Class of Warrant or Right [Line Items]

Sale of private placement warrants (in shares)

179,272

Silverview Credit Partners LP | Contingently issuable warrants

Class of Warrant or Right [Line Items]

Sale of private placement warrants (in shares)

87,728

Service Provider

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 10

Sale of private placement warrants (in shares)

7,500

Granite Creek Capital Partners LLC

Class of Warrant or Right [Line Items]

Exercise price of warrant (in dollars per share) | $ / shares

$ 0.001

Sale of private placement warrants (in shares)

48,530

111,619

Warrants outstanding | $

$ 2,202,000

Warrants - Rollforward (Details

Warrants - Rollforward (Details) - $ / shares		6 Months Ended
	Dec. 29, 2023	Oct. 13, 2024
Class Of Warrant Or Right, Outstanding, Rollforward [Roll Forward]
Warrants outstanding, beginning (in shares)	354,436	28,797,500
Granted (in shares)		1,041,792
Expired (in shares)		0
Exercised (in shares)		0
Warrants outstanding, ending (in shares)		29,839,292
Class Of Warrant Or Right, Weighted-Average Exercise Price, Rollforward [Roll Forward]
Warrants, Weighted-Average Exercise Price, beginning (in dollars per share)		$ 9.58
Granted (in dollars per share)		0.01
Expired (in dollars per share)		0
Exercised (in dollars per share)		0
Warrants, Weighted-Average Exercise Price, ending (in dollars per share)		$ 9.25

Warrants - Warrant Liability (D

Warrants - Warrant Liability (Details) - USD ($) $ in Thousands		3 Months Ended			5 Months Ended	6 Months Ended
	Sep. 03, 2024	Oct. 13, 2024	Jul. 21, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024
Warrants And Rights Outstanding Rollforward [Roll Forward]
Reclassification of liability-classified warrants		$ (1,864)		$ (1,834)	$ 0	$ 1,864
Issuance of warrants		67		173
Change in fair value		(3,573)		$ (1,759)	$ (1,350)	(6,248)
Warrants
Warrants And Rights Outstanding Rollforward [Roll Forward]
Beginning balance		3,373	$ 5,411			5,411
Reclassification of liability-classified warrants	$ 1,864	1,864
Issuance of warrants	$ 401	401
Change in fair value		(4,928)	(2,038)
Ending balance		766	$ 3,373			$ 766
Warrants | Oaktree
Warrants And Rights Outstanding Rollforward [Roll Forward]
Issuance of warrants		$ 859

Net Loss Per Share - Basic and

Net Loss Per Share - Basic and Diluted Net Loss Per Share of Common Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				5 Months Ended	6 Months Ended
	Oct. 13, 2024	Jul. 21, 2024	Oct. 15, 2023	Jul. 23, 2023	Oct. 15, 2023	Oct. 13, 2024
Numerator:
Net loss	$ (9,310)	$ (10,006)	$ (7,283)	$ (3,046)	$ (10,329)	$ (19,316)
Cumulative unpaid dividends on Series I redeemable convertible preferred stock	0		(394)		(528)	0
Change in redemption amount of redeemable convertible preferred stock	0		0		(1,423)	0
Net loss attributable to common stockholders	(9,310)		(7,677)		(12,280)	(19,316)
Net loss attributable to common stockholders	(9,310)		(7,677)		(12,280)	(19,316)
Earnings allocated to participating securities	0		0		0	0
Net loss available to common stockholders, basic	(9,310)		(7,677)		(12,280)	(19,316)
Net loss available to common stockholders, diluted	$ (9,310)		$ (7,677)		$ (12,280)	$ (19,316)
Denominator:
Weighted average common shares outstanding, basic (in shares)	43,099,877		12,066,454		12,094,424	42,905,215
Dilutive awards outstanding (in shares)	0		0		0	0
Weighted average common shares outstanding, diluted (in shares)	43,099,877		12,066,454		12,094,424	42,905,215
Loss per share:
Basic (in dollars per share)	$ (0.22)		$ (0.64)		$ (1.02)	$ (0.45)
Diluted (in dollars per share)	$ (0.22)		$ (0.64)		$ (1.02)	$ (0.45)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings (Loss) Per Share (Details) - shares	3 Months Ended		5 Months Ended	6 Months Ended
	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	4,297,000	5,269,000	5,269,000	4,297,000
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	173,000,000	0	0	173,000,000
Restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	377,000,000	0	0	377,000,000
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	23,985,000	194,000	194,000	23,985,000
Contingently issuable warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	2,738,000	141,000	141,000	2,738,000
Preferred Stock (as converted to common stock)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	0	24,312,000	24,312,000	0
Convertible debt (as converted to common stock)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of loss per share (in shares)	0	948,000	948,000	0

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	Oct. 13, 2024	Apr. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Estimate of possible cost	$ 464	$ 464

Related Party Transactions (Det

Related Party Transactions (Details) - Related Party - USD ($) $ in Thousands	3 Months Ended		5 Months Ended	6 Months Ended
	Oct. 13, 2024	Oct. 15, 2023	Oct. 15, 2023	Oct. 13, 2024	Apr. 28, 2024
RELATED PARTY TRANSACTIONS
Accounts payable	$ 9,482			$ 9,482	$ 8,633
Design Services And Equipment Supply
RELATED PARTY TRANSACTIONS
Related party transaction	14	$ 10	$ 21	676
Accounts payable	$ 1,519			$ 1,519	$ 1,918